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 Genotoxic stress is an important threat to the wellbeing of cells in the human body. 
Damages to genetic material contribute to the aging process and can lead to mutations that 
cause cancer or other diseases. The DNA damage response has therefore been studied 
extensively. With recent advancements in the field, it became clear that the study of lncRNAs 
and RBPs is necessary to broaden our understanding of DDR. This thesis aimed at discovery 
and characterization of lncRNAs and their associated proteins involved in DDR to provide 
novel insight into the regulation of this process. 
 Firstly, we have attempted to develop a new methodology that would allow to study 
RNA-protein interactions with high efficiency and ease of use. We have designed two new 
experimental approaches to overcome limitations of previously established methods. Their 
usefulness, however, turned out to be limited and we were unable to provide a reliable 
improvement to existing methodologies. 
 Secondly, we provided an extensive atlas of the transcriptional landscape of MCF-7 
cells during the DDR. We employed three different high-throughput RNA sequencing 
approaches to provide a comprehensive analysis of the transcriptome. Our efforts led to 
identification of differentially expressed transcripts regardless of their polyadenylation or 
stability, or towards their presence in existing genome annotations. We have provided a 
foundation for future functional studies of lncRNAs potentially involved in DDR and 
investigated four lncRNAs upregulated in this condition in more detail. 
 Thirdly, we have provided a new important insight into regulatory mechanism of 
DDX3 – a protein, which has been previously reported to associate with lncRNAs and is 
implicated in both DDR and tumorigenesis. We have described the nature of DDX3-lncRNAs 
interactions on a transcriptome-wide scale and furthered our understanding of DDX3 
mediated regulation of translation. We have determined the global effects of DDX3 depletion 
on the abundance of mRNAs and their translation efficiency. In combination with the analysis 
of DDX3-mRNA binding specificity those results show that the protein is required for 






Genotoxischer Stress ist eine ständige Bedrohung der Integrität menschlicher Zellen. 
Schäden im genetischen Material tragen zum Alterungsprozess bei und zur Entstehung von 
Krebs und anderen Krankheiten. Die DNA-Schadensantwort (DSA) ist daher ein intensiv 
bearbeitetes Forschungsfeld. Neue Erkenntnisse haben gezeigt, dass auch RNA-bindende 
Proteine (RBPs) und nicht-codierende RNAs (ncRNAs) vermehrt erforscht werden müssen 
für das Verständnis der DSA. Diese Doktorarbeit hatte zum Ziel, ncRNAs und die damit 
assoziierten RBPs zu identifizieren und charakterisieren, um die DSA besser zu verstehen. 
Im ersten Teil haben wir versucht, eine neue Methode zu etablieren, um RBP-ncRNA-
Interaktionen effizient und einfach zu identifizieren. Mit zwei neuen Prozeduren versuchten 
wir, die bisherigen Methoden zu verbessern. Ihre Nützlichkeit war aber beschränkt, und wir 
konnten keine nachhaltige Verbesserung der existierenden Protokolle erreichen. 
Im zweiten Teil wurde ein ausführliches Verzeichnis der Veränderung im 
Transkriptom der Zellen während der DSA erstellt. Drei verschiedene Hochdurchsatz-
Sequenziermethoden wurden verwendet, um Transkripte unabhängig von deren 
Polyadenylierungs-Status und Stabilität zu detektieren, und unabhängig davon ob sie schon 
annotiert sind. Wir haben damit das Fundament für zukünftige Forschungsprojekte gelegt, und 
vier ncRNAs auch näher untersucht. 
Im dritten Teil haben wir die Rolle des DDX3-Proteins in der Regulation der 
zellulären Genexpression untersucht. Bekannt ist, dass DDX3 mit ncRNAs interagiert, und 
sowohl in der DSA wie auch bei der Tumorentstehung relevant ist. Wir haben die DDX3-
ncRNA-Interaktionen Transkriptom-weit beschrieben, und die Rolle von DDX3 in der 
Regulation der Translation charakterisiert. Zusammengenommen zeigen unsere Ergebnisse, 
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1.1. Non-coding RNAs in human biology 
The central dogma of molecular biology put the role of RNA as a carrier of genetic 
information from DNA to production of proteins. The last decades of study, however aided by 
the development of high throughput sequencing techniques showed that RNA molecules play 
much more diverse roles in cells biology than originally appreciated. Alongside messenger 
RNAs (mRNAs), which provide a template for protein translation, and transcripts centered 
around production of proteins such as ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs) 
other species of transcripts that are not directly involved in a process of translation have been 
discovered and functionally characterized. Discovery of their functionality directly challenged 
the notion that the sole function of RNA is to produce proteins and led to revision of the 
central dogma of molecular biology. Those transcripts are collectively named non-coding 
RNAs (ncRNAs) and are arbitrarily divided into two groups based on their size. Small 
ncRNAs are shorter than 200nt in length and long non-coding RNAs (lncRNAs) are longer 
than 200 nt. In mammalian cells there are three main subgroups of small ncRNAs: micro 
RNAs (miRNAs), short interfering RNAs (siRNAs) and piwi-interacting RNAs (piRNAs). 
Those classes of transcripts differ between each other in regard of origin, processing and their 
mode of action. They however share a role in regulating expression of other cellular 
transcripts. The roles of lncRNAs on the other hand are more diverse and they have been 
shown to regulate a variety of cellular processes. Overall the discoveries in the field of 
ncRNA made in last decades redefined our way of thinking about RNA and their cellular 
functions, and thus broadened our understanding of molecular biology. 
1.1.1. Properties of small non-coding RNAs 
The best studied group of small ncRNAs are miRNAs. They are ~19-24nt in length, 
single stranded transcripts that regulate gene expression on post transcriptional level. 
MiRNAs are produced from long RNAs called primary miRNAs (pri-miRNAs), which are 
transcribed by RNA polymerase II (Pol II). Those transcripts contain one or more about 80 
base pair long stem loops, which are released to give rise to precursor miRNAs (pre-miRNAs) 
(Han et al., 2006). Generation of pre-miRNAs is dependent on the Microprocessor complex, 
which recognizes specific motifs in pri-miRNA and cleaves miRNA hairpins from the 
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primary transcript. The microprocessor complex is made of two proteins: an RNase III 
enzyme Drosha and the RNA binding protein DiGeorge Critical Region 8 (DGCR8), which 
are present in the complex as a hetero-dimer (Nguyen et al., 2015; Denli et al., 2004; Lee et 
al., 2003; Gregory et al., 2004). The resulting pre-miRNA is next transported to the cytoplasm 
via the Exportin 5 pathway (Yi et al., 2003; Lund et al., 2004) and is further cleaved by 
another RNAse III enzyme called Dicer 1 (DCR1) (Hutvagner et al., 2001; Taylor et al., 2013; 
Ma et al., 2012). DCR1 activity leads to the release of 21-23nt long double stranded miRNAs 
(Zhang et al., 2002; Ma et al., 2004). One of the strands of the duplex is bound by an 
Argonaute (Ago) protein forming the RNA induced silencing complex (RISC) (Liu et al., 
2004; Meister et al., 2004; Rivas et al., 2005). The RISC can target transcripts through the 
sequence complementarity of the loaded miRNA and lead to gene silencing by target mRNA 
degradation or translational inhibition (Rand et al., 2005; Diederichs and Haber 2007). 
Usually, target recognition by miRNAs is mediated by base pairing between the seed 
sequence of the miRNA (nucleotides 2-8 at miRNA 5’end) and sequences in the 3’ 
untranslated region (UTR) of the target RNA. The choice in miRNA mediated gene silencing 
by inhibition of translation or by transcript degradation appears to depend on degree and 
nature of sequence complementarity between the target RNA and the miRNA (Pasquinelli, 
2012; Fabian and Sonenberg, 2012; Czech and Hannon, 2010). Throughout the years, 
miRNAs have been shown to be important regulators of many pathways in mammalian cells 
including tissue differentiation (Chen et al., 2006; Krichevsky et al., 2006). Their 
misregulation have also been associated with diseases, including viral infections (Triboulet et 
al., 2007) and cancer (Michael et al., 2003; Takamizawa et al., 2004; He et al., 2005; 
Hayashita et al., 2005). The relevance of miRNAs as regulators of cells biology is reinforced 
by the fact that more than half of the human transcriptome has been predicted to be regulated 
by miRNAs, which means that they potentially regulate most major human gene pathways 
(Krol et al., 2010; Winter et al., 2009). 
1.1.2. Properties of long non-coding RNAs 
 Another group of RNA regulators that are being increasingly appreciated as regulators 
of cellular physiology are lncRNAs. They are generally classified as RNA molecules longer 
than 200 nt that have no or little predicted coding potential. Those molecules are pervasively 
transcribed from eukaryotic genomes and rise from both intergenic regions and protein coding 
gene bodies (Okazaki, et al., 2002; Affymetrix ENCODE Transcriptiome Project, 2009; 
Katayama et al., 2005; Laurent et al., 2012). The wealth of cellular lncRNAs is vast and 
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consists of transcripts of diverse characteristics including spliced and unspliced, nuclear and 
cytoplasmic, polyadenylated and non-polyadenylated molecules. In addition, there is a class 
of transcripts, which are subjected to a process of back splicing which joins their 3' and 5' 
ends resulting in a circular transcript (circRNA), which are generally considered to be 
lncRNAs (Salzman et al., 2012).  
 Although many lncRNAs are processed similarly to mRNAs, i.e. being subject to 
capping, splicing and polyadenylation, all of them were initially considered to be of little 
physiological relevance. When lncRNAs were discovered, RNA was believed to be solely an 
intermediate between information coded in DNA and protein synthesis. For this reason, long 
RNA molecules not involved in production of proteins were dubbed ―transcriptional noise‖. It 
was hypothesized that RNA polymerase II randomly initiates transcription throughout the 
genome, giving rise to both functional mRNA molecules and non-functional lncRNAs. 
Several features however pointed to functionality of certain lncRNAs, including conservation 
of promoters (Carninci et al., 2005; Derrien et al., 2012), regulation by transcription factors 
(Cawley et al., 2004; Guttman et al., 2009) and chromatin signatures typical for active gene 
expression (Guttman et al., 2009; Derrien et al., 2012). It was also shown that the number of 
RNA molecules not coding for proteins in a genome correlates well with organism 
complexity, in contrast to the number of protein coding sequences (Taft and Mattick, 2003; 
Liu et al., 2013). This observation pointed to the possibility that lncRNAs may constitute a 
novel layer of regulation of cell physiology. The notion that lncRNAs represent nothing more 
than transcriptional noise was directly challenged by the discovery of functional lncRNAs, the 
earliest notable example of which is Xist (Brown et al., 1992). 
1.1.3. Functions of long non-coding RNAs 
Xist (X inactive specific transcript) is a long non-coding RNA that is essential in X 
chromosome inactivation and formation of the Barr body in placental mammals. Xist coats 
the entire inactivated X chromosome and works to recruit Polycomb repressive complexes 1 
and 2 (PRC1 and PRC2) (Zhao et al., 2008). This leads to deposition of repressive epigenetic 
modifications like histone H3 hypo-acetylation and H3K27 methylation resulting in 
transcriptional inactivation of almost the entire chromosome (Yang et al., 2010). Other 
lncRNAs have been shown to regulate diverse cellular processes including chromatin 
modification (Pandey et al., 2008; Khalil et al., 2009; Tsai et al., 2010), formation of 
specialized subnuclear organelles (Sunwoo et al, 2009; Bond et al., 2009), fine tuning the 
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miRNA pathways by sponging miRNA molecules (Du et al., 2016; Wu et al., 2017; Shan et 
al., 2018), regulation of splicing (Gonzalez et al. 2015; Romero-Barrios et al, 2018) and 
enhancer activity (Kim et al., 2010; Ørom et al., 2010). Moreover, many studies showed links 
between lncRNAs and differentiation and development (Amaral and Mattick 2008; St Laurent 
et al., 2016) as well as different diseases, including schizophrenia (Barry et al., 2014), cancer 
(Mourtada-Maarabouniet al., 2009; Gutschner et al., 2013; Liu et al., 2014), cardiovascular 
diseases and diabetes (Broadbent et al., 2008; Burd et al., 2010; Pasmant et al., 2011). 
 Despite indirect indications for lncRNAs functionality as a class of transcripts and 
increasing number of studies ascribing functions to diverse members of this group of 
molecules many questions and doubts remain. It is still a matter of speculation to what extent 
lncRNAs are transcriptional noise of the cell and how many lncRNA genes give rise to 
functional transcripts, or their transcription itself has a regulatory role. Determining functions 
of plethora of lncRNAs is an important challenge of modern biology. However, due to 
properties of non-coding transcripts their study is often difficult. Many lncRNAs have 
relatively low expression levels when compared to mRNAs. They are often transcribed 
transiently during development and/or, in specific cell types, resulting in low levels of 
transcripts detected in whole tissue samples (Derrien et al., 2012; Deveson et al., 2017). Low 
levels of lncRNA expression are sometimes explained by the notion that it is the process of 
their transcription rather than utilization of resulting transcript that exerts the function of 
lncRNAs. This notion is at least in part supported by recent studies showing that many long 
intergenic non-codind RNAs (lincRNAs) are inefficiently co-transcriptionally spliced and 
terminated in comparison to mRNAs, thus being rapidly degraded by the RNA exosome 
(Schlackow et al., 2017). This observation may reflect a mechanism in which indeed the 
functions of some lincRNAs are carried out by the process of transcription itself and resulting 
transcripts are non-functional and thus quickly degraded. An alternative explanation is that 
observed transcription of lincRNAs is non-functional and they require a specific cellular 
context to be stabilized to exert their function. Moreover, conservation of lncRNA sequences 
is significantly lower than conservation of protein coding genes (Mouse Genome Sequencing 
Consortium et al., 2002). They also contain relatively few defined RNA motifs within their 
sequences. It is possible, that many non-coding transcripts exert their functions through 
formation of secondary structures, thereby requiring less strict sequence conservation then 
their protein coding counterparts. Another issue that may complicate the evaluation of the 
biological relevance of ncRNAs is the fact that they may carry out highly specialized 
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functions. It is possible for genes to escape phenotypic screens such as knock-downs of some 
of them affect phenotypes not commonly examined in such experiments or have effects that 
are difficult to observe. This phenomenon is potentially problematic for functional study of all 
classes of genes, but it has been speculated to be more common in case of lncRNAs than of 
protein coding transcripts (Mattick 2018).  
 In recent years, the need to reevaluate the lack of protein coding potential of many 
lncRNAs became apparent. The initial classification of RNA molecules as non-coding was 
based on their lack of open reading frames containing at least 100 codons, associated with 
lack of ability to code for typical functional protein products (The FANTOM consortium et 
al., 2002; Deveson et al., 2017; Kang et al., 2017). With the advent of ribosome profiling 
technology, which evaluates direct association of the translation machinery with translated 
transcripts, it became apparent, however, that many short open reading frames can be 
translated into small peptides. Those peptides have been showed to rise from regions of 
mRNAs annotated as untranslated as well as from lncRNAs (Ji et al., 2015; Bazin et al., 
2017). It has been shown that 40% transcripts previously considered as non-coding associate 
with actively translating ribosomes. This observation suggests that many transcripts classified 
previously as non-coding may in fact also function as mRNAs. The lncRNA-ribosome 
associations observed in ribosome profiling experiments, however, have to be considered with 
care. Although the experimental setup allows to distinguish between the RNAs that are 
associating with ribosomes in a non-consequential manner and those that are actually engaged 
in translation, it does not provide information on stability or functionality of produced 
peptides. It has been reported that translated lncRNAs are prevalently cytoplasmic and the 
majority of their peptide products are considered to be unstable by-products of ribosome 
activity (Ji et al., 2015). The prevalence of lncRNA-ribosome interactions not resulting in 
production of stable, functional peptides in human cells is supported by low numbers of 
peptides originating from lncRNAs being identified with mass spectrometry approaches (Sun 
et al., 2014; Crappé et al., 2015). The examples of lncRNA encoded small peptides with 
biologically relevant functions are, however, numerous (Kondo et al., 2007; Anderson et al., 
2015; Nelson et al., 2016; Matsumoto et al., 2017; Huang et al., 2017; D'Lima et al., 2017). It 
is therefore important to consider regulatory roles of lncRNAs as potential peptide coding 
messages in their functional study, especially when their localization is cytoplasmic. 
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1.1.4. Challenges in study of long non-coding RNAs 
Due to their specific properties, studying lncRNAs requires not only careful 
consideration, but also use of novel experimental approaches. Investigating transcript-protein 
interactions is of particular interest, as lncRNAs are known to exert their functions through 
interactions with proteins. Investigation of RNA sequences bound to a specific protein of 
interest has been achieved with success thanks to methods like RNA immunoprecipitation 
(RIP) and different variants of cross-linking and immunoprecipitation (CLIP) (Zhao et al., 
2010; Ule et al., 2003; Hafner et al., 2010). However, de-novo identification of proteins 
interacting with a transcript of interest is more difficult. This is particularly challenging in 
case of lncRNAs, due to their general low abundance and stability. Typical RNA pull-down 
experiments involve incubation of immobilized in-vitro transcribed molecules of interest with 
cellular lysates to identify proteins that are capable of binding their sequence (Lee et al., 2013; 
Treiber et al., 2017). However, the usefulness of those approaches in the study of RNAs 
proved to be limited. The protein-RNA interaction that is being captured takes place in-vitro 
and may not reflect binding maintained in living cells. Perhaps for this reason classic RNA 
pull-down experiments are associated with high background levels (Treiber et al., 2017). To 
better understand the regulatory nature of cellular transcripts, unbiased and highly sensitive 
methods allowing the determination of the protein interactome of a specific transcript are 
necessary. A number of approaches that isolate specific RNAs expressed in cells that bear 
short sequence tags embedded in the transcript were developed to meet this requirement. In 
those systems, in vivo interactions are being captured and usage of cross-linking is possible. 
Variants of those methods utilize S1 aptamere, MS2 tagging, StreptoTag and others (Bachler 
et al., 1999; Srisawat and Engelke 2001; Yoon et al., 2012; Leppek and Stoecklin 2013). 
Those approaches turned out to be functional but were put to little use in the lncRNA field, 
probably due to their relatively low stringency and unsatisfying efficiency. Another, more 
recently developed family of methods, employed affinity purification of transcripts of interest 
from cellular lysates with biotinylated oligonucleotides. Those methods proved much more 
useful in identifying RNA-interacting proteins than previously developed systems. Three 
similar approaches were created independently: capture hybridization analysis of RNA targets 
(CHART), RNA Antisense Purification (RAP) and Chromatin Isolation by RNA Purification 
(ChIRP) (Simon et al., 2011; Engreitz et al., 2013; Chu et al., 2011). Originally, those 
methods were developed to study lncRNA interactions with chromatin, but later were 
combined with mass spectrometry to identify RNA-bound proteins. They utilized biotinylated 
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RNA or DNA probes of various lengths antisense to the target transcript for purification. All 
three provided a remarkable improvement in terms of specificity and efficiency compared to 
preexisting methods. None of them require usage of genetic engineering of cells to be used 
and can target endogenous transcripts. A drawback shared by them however is their cost, as 
for each target transcript a unique array of biotinylated oligonucleotides needs to be 
purchased. Moreover, a limiting step in identifying proteins bound by the target RNA is 
current mass spectrometry technology. To be identified in this approach, the amounts of 
proteins purified have to exceed a certain threshold, which in case of targeting lowly 
expressed RNAs is difficult to achieve. However, the mass spectrometry technologies are 
being constantly perfected, and their sensitivity is being increased (Li et al., 2017; Iwamoto 
and Shimada 2018). It seems likely that in the following years improvements in those 
technologies will allow for reliable identification of much lower amounts of proteins than 
currently possible. This will make identification of proteins interacting with a single transcript 
more feasible. For the time being, however, the usefulness of methods identifying proteins 
interacting with a single RNA of interest is restricted to relatively highly expressed targets. 
The limited toolbox of methods allowing effective and cost-efficient investigation of lncRNA 
interactors calls for development of new approaches. 
1.1.5. Properties of circular RNAs 
 Another group of transcripts that has unexpectedly emerged as important regulators of 
cells biology are circRNAs. They do not have a free 5’ or 3’ terminus, are generally classified 
as lncRNAs and are much more stable then linear transcripts, because of a lack of free termini 
that could be targeted by exonucleases. The existence of cellular RNA molecules with circular 
configuration has been reported for the first time around four decades ago (Hsu and Coca-
Prados 1979; Halbreich et al., 1980). Later examples of circRNAs being produced from 
different genes also expressing mRNAs have been reported, but their existence have been 
mostly attributed to splicing defects and their potential functions have not been studied in 
detail (Cocquerelle et al., 1992; Capel et al., 1993; Cocquerelle et al., 1993). Those early 
studies, however still yielded some information about circRNAs. Certain sequence properties 
required for their production and their high stability have been determined. Notably, 
circRNAs may exhibit a half-life of more than 48 h, whereas typical half-life of mRNAs are 
rarely longer than 10 h (Jeck and Sharpless 2014). They have also been shown to arise from 
both exonic and intronic regions of their host genes (Halbreich et al., 1980; Capel et al., 1993; 
Pasman et al., 1996; Braun et al., 1996). In the past years the advancement of high throughput 
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sequencing technology enabled in-depth analysis of circular transcripts. More than 20 000 
eukaryotic circRNAs have been identified (Glazar et al., 2014) and many among them have 
tissue specific expression patterns. CircRNAs were showed to arise from intronic and exonic 
sequences of known protein coding genes, including 5’ and 3’ UTRs as well as from 
intergenic regions of the genome (Memczak et al., 2013; Zhang et al., 2013). Recently models 
for biosynthesis of circRNAs have been presented. Most of those transcripts seem to be 
produced by the backsplicing event of joining a 5’ splice donor to an upstream 3’ splice 
acceptor (Jeck et al., 2013). The process does not show any U2 or U12 spliceosome 
preference (Guo et al., 2014). It has also been reported that exons that are circularized are 
flanked by large introns (Salzman et al., 2012; Westholm et al., 2014) and that repetitive 
sequences in the flanking intron promotes this process (Jeck et al., 2013). Alongside the 
repetitive sequences RNA binding proteins such as Quaking (QKI), RNA-binding motif 
protein 20 (RBM20), the dsRNA binding/editing protein ADAR (Ivanov et al. 2015) and 
Muscleblind (MBL) have been shown to promote the backsplicing event (Ashwal-Fluss et al., 
2014; Conn et al., 2015; Khan et al., 2016). Still, the investigation of the regulation of 
circRNA biogenesis is likely only at its beginning. 
1.1.6. Functions of circular RNAs 
 The molecular functions of circRNAs are still poorly studied. The pioneering work on 
their roles in regulation of cells biology came from two independent studies. In the first study 
a circRNA antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as) was 
discovered to be an important regulator in neuronal tissues, which is highly conserved in 
different animal species (Memczak et al., 2013). Multiple binding sites for miR-7 were 
identified on this transcript and it was shown that the circRNA is densely bound by miRNA 
effector complex. The nature of miR-7 binding sites on CDR1as was shown to be favorable 
for interaction with the silencing complex, but not extensive enough to promote degradation 
of the transcript. Thus, CDR1as was shown to be able to fine-tune the activity of miR-7 by 
acting as a sponge, which can sequester this miRNA from binding to its mRNA targets. 
CDR1as regulatory potential in animals was later studied in more details. This circRNA has 
been determined to be an important regulator of brain functions in mouse. Its interaction with 
miR-7 was confirmed in human and mouse brain. Mouse with CDR1as knock-out displayed 
neurological defects, which were associated with changed expression of genes in the brain, 
which regulate neuronal activity (Piwecka et al., 2017). The second pioneering study on roles 
of circRNAs reported a function of circular transcript named ciRS-7 originating from the 
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mouse Sry gene. This RNA acts as a molecular sponge for miR-138 (Hansen et al., 2013). The 
circRNA binding sites for miR-138 are mismatched in a way that allows RISC complex 
binding but prevents RNA cleavage. This interaction sequesters the miRNA molecules from 
binding to their mRNA target, thus fine-tuning their activity. Other studies have shown that 
different circRNAs contain binding sites for multiple miRNAs, suggesting that miRNA 
sponging may be a common feature of various circular transcripts (Zheng et al., 2016; Yang et 
al., 2016; Hsiao et al., 2017). A group of intron-retaining circRNAs have been also shown to 
act as miRNA decoys, but an additional role has been ascribed to them. They localize to 
promoters of genes they originate from, associate with Pol II and enhance the efficiency of 
transcription of their parental genes in cis (Li et al., 2015). Other circRNAs have been shown 
to play roles in processes like suppression of exonuclease mediated maturation of rRNA 
(Holdtet al., 2016) or modulating protein-protein interactions (Du et al., 2016). CircRNAs are 
generally classified as ncRNAs, however it has been shown that at least some of them actually 
are messengers used for protein translation. The indication that endogenous circular 
transcripts are being translated in human cells came from indirect lines of evidence first (Abe 
et al., 2015). Recently, however direct evidence for circRNA translation has been provided. In 
one study (Pamudurti et al., 2017) a group of circRNAs was shown to associate with 
translating ribosomes in Drosophila, presence of a protein coded by a specific circRNA in 
flies was confirmed and in-vivo translation of circRNA reporters was observed. In another 
study a circular transcript named circ-ZNF609 specifically controlling myoblast proliferation 
have been directly shown to be translated into protein (Legnini et al., 2017). Those 
discoveries directly challenge categorization of circRNAs as lncRNAs and showed that the 
family of circular transcripts is more diverse than previously expected. Other examples of 
different functions of circRNAs have been published, however most of those transcripts have 
not been studied to date and novel pathways in regulation of which they are involved are 
likely to be discovered. CircRNAs have been implied in the regulation of diverse processes in 
the human body as well as pathologies, including neurodegenerative diseases and cancer 
(Greene et al., 2017; Li et al., 2017; Bolha et al., 2017). It is evident that further study of 
circRNAs as well as linear lncRNAs is necessary to broaden our understanding of human 
biology and progression of pathologies. 
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1.2. Cellular response to genotoxic stress  
Cells in the human body have to constantly deal with factors that threaten their 
homeostasis and cause them stress. All cellular components are subject to damage, however 
alterations of DNA as a repository of cells generic material are far more dangerous than 
lesions in proteins or RNAs, which are relatively quickly turned-over. Depending on the 
source of damage, DNA may experience lesions such as modifications of bases, single strand 
breaks (SSBs), or double strand breaks (DSBs). DNA damage has the potential to interfere 
with essential cellular processes like transcription (Svejstrup, 2010) or replication (Branzei 
and Foiani, 2005) and may be lethal for the cell. Damages to genetic material contribute to 
aging process and can lead to mutations that cause cancer or other diseases (Hoeijmakers, 
2009). Efficient coping with DNA damage is critical as according to estimations each day 
every cell in human body faces tens of thousands DNA-damaging events (Lindahl, 2000). To 
deal with such a common yet dangerous threat, cells in the human body had to develop 
efficient mechanisms of coping with this so-called genotoxic stress. In response to damage of 
their genetic information cells initiate highly coordinated cascades of events. Repair of 
different kinds of DNA lesions is carried out by distinct, specialized repair pathways. Cellular 
mechanisms of dealing with genotoxic stress are generally known as DNA damage response 
(DDR) pathways. They are comprised of three major steps. First, the damage is located and 
recognized by sensor proteins. Next, repair factors are recruited to the site of damage. In the 
third step, the actual repair is carried out by effector proteins. If the damage is persistent or 
irreparable, DDR pathways signal cells to activate apoptosis (Roos and Kaina, 2006). The 
relevance of those pathways for protecting the genome is evidenced by the fact that mutations 
in factors responsible for DNA damage repair are among the most frequently accumulated in 
various cancers (Parikh et al., 2018). 
1.2.1. DNA repair mechanism 
There are five major repair pathways that resolve different types of DNA damage. 
Mismatch repair (MMR) corrects DNA mismatches, which mostly arise from mistakes of the 
proofreading activity of the replication polymerases (Ravi et al., 2006). Base excision repair 
(BER) is mainly responsible for removing modifications of the bases that do not distort the 
DNA helix (Kim and Wilson 2012). Lesions repaired by BER include for example SSBs, 
deaminated, oxidated and alkylated bases, which are commonly introduced to DNA by by-
products of cells metabolism. Nucleotide excision repair (NER) removes a wide variety of 
helix-distorting lesions including base cross-links (Orlando 2013). DNA damage sites targeted 
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by NER are commonly induced by external factors, such as the UV component of sunlight. 
Homologous recombination (HR) and non-homologous end joining (NHEJ) repair double 
strand breaks (Mao et al., 2009). NHEJ relies on direct ligation of broken DNA strands. It is 
generally considered error prone as it doesn’t include strict control for alterations or deletions 
in broken DNA ends. However, most of DSBs are repaired by NHEJ and errors do not occur 
frequently (Beucher et al., 2009). HR on the other hand is considered error free as repair is 
carried out with use of sister chromatid sequence as a template for faithful repair (Jasin and 
Rothstein 2013). This ensures that no alterations in DNA or deletions are introduced at the 
damaged site. 
1.2.2. Immediate response to double strand breaks 
The most dangerous type of DNA damage is DSB. If not repaired, they can lead to cell 
death and, if not repaired correctly, they can cause deletions or chromosomal aberrations 
(Cannan and pederson 2016). It has been shown that even a single DSB may lead to cell death 
(Bennet et al., 1993; Rich et al, 2000). Mistakes in DSB repair can potentially lead to 
development of cancer or other diseases (Moynahan et al., 2010; Merlo et al., 2016). Thus, 
proper control of those DNA lesions is critical for cell viability and maintenance of genome 
integrity. Central to the cellular response to DNA double strand breaks is a protein kinase 
called Ataxia Telangiectasia Mutated (ATM). Inactive ATM is present in the cell as a dimer. 
Upon DNA damage it is recruited to damage sites by the Mre11-Rad50-Nbs1 (MRN) 
mediator complex, which acts as a DSB sensor (Lee and Paull, 2005). This recruitment 
activates the kinase, which initiates complex signal transduction pathways facilitating the 
damage repair. ATM phosphorylates hundreds of substrates including other kinases, which 
then also become activated (Bekker-Jensen and Mailand 2010). Thus, the immediate DSB 
response is marked by extensive posttranslational modifications of cellular proteins. Through 
this, ATM is crucial for DNA repair, both locally at the site of damage and globally on 
cellular level. This includes cell cycle regulation, changes in transcription and pre-RNA 
splicing and alterations in chromatin structure. One of the immediate targets of ATM at sites 
of damage is the variant histone H2AX, which is being phosphorylated on Ser139 (γH2AX) 
(Burma et al., 2001). The process leads to recruitment of additional DDR proteins and 
amplification of H2AX phosphorylation further away from damage site. In consequence, 
DNA repair foci are formed. Phosphorylation of ATM targets also leads to recruitment of E3 
ubiquitin ligases. which ubiquitinate histone proteins including H2AX (Huen et al., 2007) and 
linker histone H1 (Thorslund et al., 2015). This allows further recruitment of DNA repair 
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factors and leads to strong chromatin relaxation, creating a permissive environment for repair. 
At this stage, the choice between HR and NHEJ is made. Either protein 53BP1 or BRCA1 
may be recruited to damage site. Their actions are largely antagonistic, and they promote 
NHEJ and HR respectively by recruitment of specific downstream repair proteins (Moynahan 
et al., 1999; Bothmer et al., 2010; Bunting et al., 2010). Choice between the two pathways 
seems to relay on the cell-cycle phase and the extent of DNA damage. NHEJ is active 
throughout all cell-cycle phases and is a major DSB repair pathway even in presence of active 
HR (Kakarougkas and Jeggo, 2014). HR functions only in S/G2 phase, where it is utilized to 
repair more complex DNA damage events. It is the pathway of choice when damage occurs in 
heterochromatic regions and when complex DSBs with multiple damages in close proximity 
are induced to DNA (Shibata et al., 2011; Kakarougkas et al., 2013). 
1.2.2.1. Transcriptional activity of double strand breaks 
For a long time, genomic regions harboring DSBs were believed to be fully 
transcriptionally inactive. Indeed, proper expression of genes harboring damaged DNA 
sequences is not possible and could interfere with the repair process, thus it has to be inhibited 
(Kruhlak et al., 2007; Shanbhag et al., 2010; Pankotai et al., 2012). It has been shown recently 
however, that a specialized class of transcripts is produced from the sites of DSBs. Short 
RNAs, about 21nt long, named DSB-induced small RNAs (diRNAs) and originating from 
sites of DSBs have been detected and discovered to be critical for damage repair (Wei et al., 
2012; Francia et al., 2012). They are being produced similarly to miRNAs, depending on 
DICER and DROSHA proteins, but have been shown not to function in posttranscriptional 
gene silencing. Instead, they target directly the damage site they originate from, by 
associating with long RNA products transcribed from the same genomic locations (Michelini 
et al., 2017). Those long RNAs seem to be at the same time substrates used for diRNAs 
productions and docking stations for diRNAs targeting to the damage site. γH2AX deposition 
does not seem to be dependent on those short transcripts, but they are necessary for 
recruitment of downstream repair factors, maintenance of repair foci and removal of DSBs. 
This mechanism seems to be evolutionally conserved as functional diRNAs have also been 
detected in plants (Wei et al., 2012). 
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1.2.3. Cellular environment of DNA damage repair 
In addition to triggering direct actions to repair DSBs DDR activates pathways that 
induce more global changes to cellular environment. The most obvious example of this is 
checkpoint activation, which stops progressing through the cell cycle providing time to carry 
out the DNA repair before replication or mitosis. To achieve this, ATM directly 
phosphorylates Chk2, which leads to its activation and phosphorylation of downstream targets 
resulting in cell cycle arrest at the G2/M checkpoint (Ahn et al., 2000). Another important 
example of global changes to cellular environment triggered by ATM in response to DNA 
damage is the effect it has on the gene expression programs of the cell. The central player in 
the changing transcriptional landscape of the cell in response to DSBs is the transcription 
factor p53 (Yogosawa and Yoshida 2018). Normally, the TP53/p53 protein is targeted for a 
rapid degradation and thus kept at low levels. Its activation in DDR relies mainly on the 
protein stabilization by ATM-dependent mechanisms. This is achieved through actions of 
multiple pathways, including direct phosphorylation of TP53 by ATM (Canman et al., 1998; 
Banin et al., 1998; Moumen et al., 2013). TP53 directly promotes transcription of many DNA 
repair genes. Stabilization of the protein leads to increased expression of its targets and 
reinforcement of cell cycle arrest. In case of persistent DNA damage, p53 activity may lead to 
senescence and apoptosis. The significance of TP53 for safeguarding the genome is 
underscored by the fact that it has been reported to be one of the most frequently mutated 
genes in human cancers (Lakin and Jackson 1999).  
An additional level of gene expression regulation present in response to DSBs relies 
on posttranscriptional regulation. DNA damage leads to changes in expression of many 
miRNAs, which add to complexity of regulation of expression of genes important for DDR 
(Maes et al., 2008; Templin et al., 2011; Wagner-Ecker et al., 2010; Simone et al., 2009; 
Jasson et el., 2008). DDR proteins regulate miRNA abundance both on the level of 
transcription and maturation. MiRNAs in turn are important regulators of many DDR proteins 
including ATM, H2AX and BRCA1 (Hu et al., 2009; Ng et al., 2010; Song et al., 2011; Wu et 
al., 2013; Yan et al., 2010; Wang et al., 2011). The importance of miRNA pathways in 
regulating DDR is evident as down regulation or overexpression of various miRNAs has been 
shown to lead to impairment of proper DDR (He et al., 2007; Pichiorri et al., 2010; Cannell et 
al., 2010; Breaun et al., 2008). 
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1.2.4. Long non-coding RNAs regulate DNA damage response 
Also, lncRNAs have been shown to be important regulators of cellular response to 
DNA damage. Involvement of lncRNAs in safeguarding the genome has been speculated 
before their involvement was directly shown as expression of many among them is changed in 
cancer cells (Mourtada-Maarabouni et al., 2009; Gutschner et al., 2013; Liu et al., 2014). 
Moreover, it has been shown that various non-coding transcripts expression are regulated by 
DDR pathways, including p53 (Huarte et al., 2010; Hung et al., 2011). The first example of 
such transcripts playing a direct role in response to DSBs was a study showing a low copy 
number, RNA polymerase II-transcribed, polyadenylated, uncapped transcript originating 
from a genomic region upstream of the cell cycle regulator cyclin D1 (CCND1) gene 
promoter (Wang et al., 2008). This RNA binds TLS, an RNA-binding protein that is an 
inhibitor of the histone acetyl transferase CBP/p300. When DDR is triggered, this ncRNA is 
upregulated, recruits TLS to CCND1 promoters and activate it. This leads to TLS interaction 
with CBP/p300 and repression of CCND1 transcription. Since that seminal discovery, more 
lncRNAs have been shown to play a role in regulating gene expression profiles of DDR genes 
through regulating the chromatin states of their targets. The lncRNA JADE regulates activity 
of its neighbor gene JADE1, which globally regulates histone H4 acetylation in DDR, 
contributing to establishment of specific transcriptional response to genotoxic stress (Wan et 
al., 2013). JADE regulates its target by facilitating BRCA1 interaction with CBP/p300, which 
allows for efficient induction of JADE1 expression after DNA damage. Another lncRNA, 
APTR, associates with PRC2 to target the promoter of the p21 gene, which is a direct p53 
target, responsible for cell cycle regulation (Negishi et al., 2014). This interaction results in 
deposition of H3K27me3, thus leading to transcriptional silencing. Epigenetic regulation of 
gene expression is a classic mode of action of known lncRNAs and high numbers of those 
molecules differentially expressed in response to genotoxic stress indicates that this 
mechanism may be more widespread in DDR than currently appreciated. 
Involvement of lncRNAs in response to DSBs is not restricted to regulating chromatin 
states of DDR gene promoters. They have also been shown to play roles in processes 
previously thought to depend solely on activity of DDR proteins. An example of this is 
exemplified by a lncRNA called damage induced noncoding (DINO) (Schmitt et al., 2016). 
This transcript is upregulated in DDR directly by p53. When expressed, DINO in turn 
associates with p53 to promotes its stabilization, thereby promoting a positive feedback loop. 
Depletion of DINO does not affect p53 phosphorylation, yet it is necessary for this 
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transcription factor’s ability to induce expression of its target genes. Another example of 
lncRNA regulating p53 is a product of the WD repeat containing antisense to p53 (WRAP53) 
gene (Mahmoudi et al., 2009). WRAP53 is an interesting example of a gene that encodes both 
a protein coding transcript and a lncRNA. WRAP53β codes for a protein that has a function in 
DSB repair. The second one, WRAP53γ is a lncRNA with a function in DDR that is 
mechanistically independent of the function of its protein coding sibling. This transcript 
directly interacts with the 5’ UTR of the p53 mRNA via RNA-RNA interactions to promote 
p53 expression. It appears that the function of WRAP53γ is mainly to stabilize the p53 
mRNA, as when it is knocked down it results in lower levels of both p53 protein and mRNA. 
LncRNAs have also been shown to regulate direct repair of DSBs. A non-coding transcript 
called DNA damage-sensitive RNA1 (DDSR1) has been reported to play an important 
function directly in repair through HR (Sharma et al., 2015). DDSR1 has been shown to 
interact with factors associated with HR including BRCA1 and heterogeneous nuclear 
ribonucleoprotein U-like 1 (hnRNPUL1). Loss of DDSR1 does not impair localization of 
BRCA1 and its interactors to site of DSB, instead leads to their increased accumulation. This 
accumulation is associated with reduced efficiency of HR. Thus, DDSR1 has been shown to 
be important for events downstream from binding of initial HR factors to DSB. It has been 
speculated that the role of DDSR1 in this regulation is to mediate BRCA1-hnRNPUL1 
interactions, as depletion of hnRNPUL1 results in similar HR defects. The exact molecular 
mechanism of this regulation is not known, but it is a fascinating example of previously 
unanticipated involvements of lncRNAs directly in DSB repair. 
More lncRNAs have been shown to play important roles in cellular responses to 
DSBs, however their number is so far limited. This does not mean that DDR is not regulated 
by lncRNAs to a much higher extent than currently appreciated. Research of functions of 
lncRNAs in DDR is still in its infancy, however their relevance in response to genotoxic 
stress is unquestionable. Increasing lines of evidence point to lncRNAs playing much broader 
roles in DDR then currently known. As mentioned above, high throughput RNA sequencing 
experiments show many lncRNAs with expression values changed upon induction of 
genotoxic stress. Many more among those transcripts are misregulated in cancer cells 
(Mourtada-Maarabouniet al., 2009; Gutschner et al., 2013; Liu et al., 2014), pointing to their 
potential roles as tumor suppressors or proto-oncogenes. As of now, few of those lncRNAs 
were functionally characterized, thus new ways through which non-coding transcripts play 
important roles in safeguarding the genome are likely to be discovered. Studies of roles of 
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lncRNAs in DDR and cancer are also driven by the fact that they are potentially suitable for 
targeting in treatments. Some lncRNAs have been recognized as useful cancer biomarkers (Ji 
et al., 2003; Fradet et al., 2004; Shappell 2008; Rasool et al., 2016). Many of them are also 
shown to be expressed specifically in cancer cells, which makes them good candidates for 
targeting in new cancer therapies, potentially having no side effects to the patient (Arun et al., 
2018; Renganathan and Felley-Bosco 2017). 
1.2.5. RNA binding proteins in DNA damage response 
Another group of regulators with roles in DDR that were previously underappreciated 
are RNA binding proteins (RBPs). The relevance of RBPs is evidenced for example by the 
above described roles of ncRNAs in the repair of DSBs. The functions that many lncRNAs 
exert in regulation of cellular physiology are carried out through their interaction with 
proteins. Processes like regulation of chromatin states are directly carried out by proteins, 
which are being directed to their targets by lncRNAs. Thus, the relevance of transcripts in 
regulation of DDR as described above has to be considered in concert with the relevance of 
their interacting RBPs. The importance of proteins with RNA binding properties in response 
to genotoxic stress is further supported by the fact that proteins with known function in DDR 
are highly enriched in experiments identifying the polyA-RNA-bound proteome (Baltz et al., 
2012). Indeed, increasing number of canonical DNA repair proteins are reported to interact 
with RNA to exert their function. A good example of this are the above described cases of 
p53 and BRCA1 binding to lncRNA molecules. In addition to increasing evidence of 
canonical DDR proteins having RNA binding properties, canonical RBPs are being 
recognized as regulators of DNA repair. Many such proteins have been identified in screens 
for proteins post-translationally modified in DNA damage or for those required for DDR 
(Matsuoka et al., 2007; Paulsen et al., 2009; Adamson et al., 2012). Involvement of RBPs in 
response to genotoxic stress conceptually makes sense as cells experiencing it need to regulate 
their RNA metabolism to restrict normal transcription from sites of DNA damage and 
enhance expression of genes responsible for repair. Recently, a direct approach to identify 
RBPs differentially interacting with polyadenylated RNAs was employed. Proteins binding 
polyadenylated RNAs were identified by Milek and co-workers by utilization of mRNA 
interactome capture after UV crosslink of proteins and mass spectrometry (Milek et al., 2017). 
This study revealed 266 proteins with increased binding to RNA upon IR. It showed that 
alongside known RNA-binders, a subset of DDR proteins with no previously known RNA 
interactions associated with polyadenylated transcripts upon DDR. It also showed that over 
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45% of RBPs identified to increase RNA binding upon DDR were components of the 
nucleolar proteome including a RNA helicase called DEAD-Box Helicase 54 (DDX54). In the 
study, DDX54 was discovered to bind 3’ splice sites of target mRNAs and to associate with 
spliceosomal proteins, thus regulating expression of DDR proteins including many targets of 
p53. The helicase knock-down cells exhibited lowered survival rates after exposure to IR. The 
study of DDX54 is an interesting example of involvement of RNA binding proteins in DDR 
and signifies the importance of regulation of RNA metabolism in response to genotoxic stress. 
1.2.5.1. DDX3 is implicated in DNA damage response 
Among RBPs with important roles in DDR, the DEAD-Box Helicase X-linked 3 
(DDX3) seems particularly interesting. DDX3 is evolutionally conserved from yeast to human 
(Tarn and Chang 2009). It has a crucial role in organisms as knockdown of the helicase is 
embryonically lethal (Li et al., 2014). The helicase is involved in multiple processes 
regulating gene expression on the level of RNA. The major role of DDX3 seems to be in 
regulating translation. It has been shown that the protein interacts with translation initiation 
factors and facilitates translation of mRNAs (Lee et al., 2008; Lai et al., 2008). In addition, a 
role of the helicase in supporting the assembly of functional 80S ribosome has been reported 
(Geissler et al., 2012). Roles of DDX3 in promoting translation in human cells are in line with 
discoveries from yeast, where the DDX3 ortholog Ded1 was shown to be required for general 
translation. Inactivation of Ded1 leads to polysome collapse and global downregulation of 
translation (Chuang et al., 1997; de la Cruz 1997). In human cells DDX3 depletion was not 
shown to significantly affect global translation (Lai et al., 2008). However, DDX3 is an 
essential gene and it could only be studied upon knock-down in human cells. Levels of DDX3 
expression upon knock-down, although low, may be sufficient to maintain protein function. 
Thus, extent to which DDX3 regulates translation in human cells remains a matter of 
speculation. It has been proposed that the protein is specifically required for translation 
imitation of mRNAs containing structured 5’ untranslated region (UTR) (Soto-Rifo et al., 
2012). One study reported an opposite role of DDX3 in regulation of translation. It has been 
shown that the protein represses the cap-dependent translation by interacting with Eukaryotic 
Translation Initiation Factor 4E (eIF4E) and trapping it in an inactive complex (Shih et al., 
2008). DDX3 is also an important regulator of formation of stress granules (SG). SG are 
cytoplasmic assemblies of untranslating mRNAs that aid cell survival upon environmental 
insults (Buchan and Parker 2009). DDX3 facilitates formation of SG and its interaction with 
eIF4E is necessary for this process (Shih et al., 2012). Yet another pathway in which the 
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helicase seems to be involved is post-transcriptional gene silencing. DDX3 has been shown to 
facilitate its efficiency and to co-localize in cytoplasm with Ago2 (Kasim et al., 2013). What 
makes DDX3 mediated RNA regulation even more complex is the fact that it has also been 
reported to associate with lncRNAs, albeit to a much lower extent in comparison to its 
binding to mRNAs (Oh et al., 2016). The relevance of DDX3-lncRNA interactions has not 
been studied, but it seems plausible that as a RNA helicase it may play a role in their 
biogenesis or turnover. The protein has also been directly shown to play a role in regulating 
response to genotoxic stress. Its functions in this process are not fully understood, however 
DDX3 is known to associate with p53, regulate its accumulation and control p53 dependent 
apoptotic pathways after induction of genotoxic stress (Sun et al., 2013). In addition, the 
previously mentioned study by Milek and co-workers showed that DDX3 binding to 
polyadenylated RNAs is increased in irradiated cells, suggesting that it may play a role in 
DDR. 
Dysfunctions in DDX3 have been reported to be associated with diseases, most 
notably with cancers. DDX3 was shown to be a proto-oncogene, capable of promoting 
metastasis in breast cancer (Botlagunta et al., 2008). On the other hand, it has been shown to 
also function as a tumor suppressor, through its regulation of p21 gene expression (Chao et 
al., 2006). The seemingly contradicting functions of the helicase in tumorigenesis may be 
explained by the plethora of cellular processes in control of which DDX3 is involved. The 
discrepancies in reported functions of DDX3 in tumorigenesis may be at least in part 
explained in differences in cellular context of different cell lines and types of cancer studied. 
It is however clear that mutations in DDX3 are common in cancer. DDX3 appears to be 
especially relevant in medulloblastomas associated with aberrations in Wingless/Integrated 
(WNT) signaling pathway in children and in medulloblastomas associated with aberrations in 
sonic hedgehog (SHH) signaling pathway in adults, where it has been reported to be mutated 
in over 50% and over 60% of cases respectively (Northcott et al., 2012; Kool et al., 2014). 
Those mutations seem to occur exclusively in the helicase domains of the protein (Pugh et al., 
2012; Epling et al., 2015; Floor et al., 2016), which points to a relevance of the RNA 
dependent functions of DDX3 in these types of cancer. The roles that DDX3 seems to play in 
metastasis led to development of therapies targeting it for cancer treatment (Bol et al., 2015; 
Heerma van Voss et al., 2015; Wilky et al., 2016). The exact mechanisms involving DDX3 in 
cancer remain not fully understood, however and further study of this multi-functional 
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helicase are warranted. In depth knowledge of DDX3 molecular functions may contribute to 






2.1. Materials for cell culture 
2.1.1 Cell lines 
Flp-In T-REX HEK293 – a human kidney cell line immortalized with adenovirus 5 
DNA containing a single stably integrated FRT site at a transcriptionally active genomic locus 
and a stably expressed Tet repressor (Invitrogen cat. no. R75007) was purchased from 
Thermo Fisher Scientific. 
MCF-7 – a human breast adenocarcinoma cell line (ATCC cat. no. HTB-22) was 
purchased from ATCC 
2.1.2. Chemicals and antibiotics for cell culture 
Table 1. Chemicals used for cell culture. 
Full name Short name Supplier Product no. 
Dulbecco's Modified Eagle 
Medium (DMEM) Highglucose 
DMEM 
(highglucose) Thermo Fisher Scientific 11965092 
Opti-MEM I Reduced Serum 
Medium Opti-MEM Thermo Fisher Scientific 31985070 
Fetal Bovine Serum FBS Thermo Fisher Scientific 26140079 
L-Glutamine (200 mM), liquid Glutamine Thermo Fisher Scientific 25030081 
Trypsin-EDTA (0.05%) Trypsin Thermo Fisher Scientific 25300054 
Phosphate buffered saline, pH 7.4 PBS Thermo Fisher Scientific 10010023 
4-thio uridine 4sU Chem Genes RP-2304 
Dimethyl sulfoxide DMSO Carl Roth GmbH A994 
Hygromycin  Hyg Invivogen ant-hg-5 
Puromycin Puro Invivogen ant-pr-1 
Doxycicline Dox Sigma-Aldrich D9891 
 
2.2. Antibodies, siRNAs and plasmids 
Table 2. Antibodies used in this work 
Name Origin Supplier Product no. 
Primary antibodies 
   DDX3 Rabbit Bethyl Laboratories, Inc. A300-474A 
Vinculin Mouse Sigma-Aldrich V9131 




   Amersham ECL Rabbit 
IgG, HRP-linked  Donkey Ge Healthcare Life Sciences NA934 
Amersham ECL Mouse 
IgG, HRP-linked Sheep Ge Healthcare Life Sciences NA931 
 
Table 3. siRNAs used in this work. 































GCCAGAATGCGGTGATCAA siTOOLs Biotech 
siPOOL negative control Proprietary siTOOLs Biotech 
siLINC00475 AGACAGAAGAUGUGGAAAAUU Eurofins Genomics 
siLINC01021 CAUAGAUGCAAUAAGGUUUUU Eurofins Genomics 
siTCERG1L-AS1 CAAUAUAUCCCAGUGUAAAUU Eurofins Genomics 
siUNC5B-AS1 AGGCCUUCCGCAAAGUGUUUU Eurofins Genomics 
 
Table 4. Plasmids used in this work. 
Name Origin Description 
pENTR4 Thermo Fisher Scientific  gateway entry vector 
pFRT-TO-FLAG-HA-
DEST Spitzer et al., 2013 gateway destination vector 




pFRT-TO-GFP Spitzer et al., 2013 plasmid expressin GFP 
pcDNA5-FRT-TO Thermo Fisher Scientific expression vector 
pHR510-mAIDHA-RFP System Biosciences 
mAID CRISPR homology 
recombination vector background 
pHR310-mAIDHA-RFP System Biosciences 
mAID CRISPR homology 
recombination vector background 
px458 Ran et al., 2013 
Cas9 and CRISPR guide RNA 
expressing vector background 






vector containing human codon 




vector containing DDX3 
homology arms for CRISPR 
knock-in 
 
2.3. List of oligonucleotides 
Table 5. Primers used for molecular cloning. 









































Table 6. Primer used for amplification in qRT-PCR 
Forward Primer 
Sequence (from 5' 
end) Reverse Primer 
Sequence (from 5' 









































C17hr:80 454 535- 







Table 7. Primers used for 3’ RACE 






















































2.4. Buffers and solutions 
Table 8. Buffers and solutions used in this work 
Buffer Composition 
2x SDS loading 
buffer 
100 mM Tris-Cl (pH 6.8); 4% (w/v) SDS; 0.2% (w/v) bromophenol blue; 
20% (v/v) glycerol; 200 mM DTT 
TBS-T 20 mM Tris; 150 mM NaCl; 0.1% Tween 20; pH 7.6 
Fixation 
Solution I 30%; 15% acetic acid 
Fixation 
Solution II 
25% ethanol; 4.1% (w/v) NaOAc; 0.3% (w/v) Na2S2O3-5H2O; 0.125% 
glutaraldehyde 
Staining 
Solution 0.1 % AgNO3; 0.011% formaldehyde 
Developer 
Solution 2.5% Na2CO3; 0.011% formaldehyde 
NP-40 lysis 
buffer 
50 mM HEPES-KOH; 150 mM KCl; 2 mM EDTA; 1 mM NaF; 0.5% (v/v) 
NP-40; 0.5 mM DTT; complete EDTA-free protease inhibitor cocktail; pH 
7.4 
2x Proteinase K 









50 mM HEPES-KOH; 500 mM NaCl; 2% (v/v) NP-40; 2 mM DTT; 
complete EDTA-free protease inhibitor cocktail; pH 7.4 
Mammalian 
Polysome Buffer 
TRIS-HCl (pH 7.4); 100 Mm; NaCl 750 mM; MgCl2 25 mM; DTT 1 mM; 




TRIS-HCl (pH 7.4) 100 Mm; NaCl 750 mM; MgCl2 25 mM; DTT 1 mM; 
CHX 100 ug/ml; Triton X-100 1 % (v/v); Turbo DNase 25 U/ml 
2x Formamide 
Loading Buffer  
95% formamide; 20 mM EDTA (pH 8.0); 0.05% (w/v) bromophenol blue; 
0.05% (w/v) xylene cyanol 
1x TBE 220 mM Tris; 180 mM Boric acid; 5 mM EDTA pH 8.0 
High Salt Wash 






3.1. Mammalian cell culture 
3.1.1. Media composition for cell culture 
 Q-medium – DMEM (high glucose), supplemented with 10% FBS and 2 mM L-
glutamine. 
3.1.2. Culturing of mammalian cells 
 Adherent HEK293 and MCF-7 cells were grown in Q-medium and subcultured two 
times a week. Confluent cells were first washed with PBS and incubated with 1x Trypsin-
EDTA at 37ºC for a few minutes, until cells detached from the plate surface. Trypsinization 
was stopped by addition of serum containing media. A defined volume of cell suspension 
(typically 1/8 or 1/10 volume) was transferred to a new plate with fresh culture medium. 
3.1.3. Freezing and thawing of mammalian cell lines 
 After reaching confluency on a 10 cm dish cells, were trypsinized and centrifuged for 
2 min at 300 xg. The cell pellet was resuspended in 8 ml of Q-medium, containing 10% 
DMSO and cell suspensions were aliquoted in 2 ml cryovials at 1 ml/vial. Vials were placed 
in a Cryo-container and stored overnight at -80ºC. The next day the vials were placed in a 
liquid nitrogen tank for storage. 
 To reculture cells, cryovials containing frozen cells were thawed in a water bath at 
37ºC. Cells were transferred to a sterile 15 ml tube and mixed with 8 ml of growth medium. 
Tubes were centrifuged for 2 min at 300 g. Supernatants were discarded from pelleted cells 
and pellets were resuspended in 10 ml of growth medium. Cell suspensions were transferred 
to fresh 10 cm plates and cells were cultured according to description in section 3.1.1. 
3.1.4. Reverse siRNA transfection 
 SiRNAs were resuspended in RNAse-free water and aliquoted. On the day of 
transfection, 80 pM siRNAs was diluted in 150 μl Opti-MEM and mixed with 150 μl Opti-
MEM, containing 9 μl Lipofectamine RNAiMAX Transfection Reagent (Thermo Fisher 
Scientific). After 5 min incubation at room temperature, siRNA-Lipofectamine mixtures were 
transferred to 6-well plates. Trypsinized MCF-7 cells in 1700 μl medium were added to each 
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well, resulting in final siRNA concentration of 40 nM. 24h after transfection, medium was 
exchanged, and cells were harvested 48h after transfection. Knock-down efficiency was 
confirmed with qRT-PCR. 
 Transfection with siPools was performed in the same way as for single siRNAs, with a 
final siRNA concentration used 3 nM instead of 40 nM. 
3.1.5. Forward DNA transfection 
Forward DNA transfection for transient expression 
On the day of transfection 12.5 μg of plasmid DNA was diluted in 750 μl Opti-MEM 
and mixed with 750 μl Opti-MEM, containing 11 μl Lipofectamine 2000 DNA Transfection 
Reagent (Thermo Fisher Scientific). After 5 min incubation at room temperature DNA-
Lipofectamine mixtures were transferred to cells grown on 10cm dishes (confluency around 
60%), containing 8.5 ml of fresh medium. 24h after transfection medium was exchanged and 
doxycycline was added to final concentration of 1 μg/ml to induce expression from the 
plasmid. 48h after transfection, cells were washed with PBS and harvested. 
For every transfection experiment, transfection with a plasmid expressing GFP protein 
was performed and used to estimate transfection efficiency by observation under fluorescent 
microscope. Only cells from transfections displaying more than around 70% successfully 
transfected cells for the positive control plasmid were used for experiments. 
Forward DNA transfection for generation of stable cell lines 
On the day of transfection 2.5 μg of plasmid DNA was diluted in 150 μl Opti-MEM 
and mixed with 150 μl Opti-MEM, containing 2 μl Lipofectamine 2000 DNA Transfection 
Reagent. After 5 min incubation at room temperature, DNA-Lipofectamine mixtures were 
transferred to cells grown on in 6-well format (confluency around 70%), containing 1.7 ml of 
fresh medium. 24h after transfection, medium was exchanged and 48h after transfection cells 
were trypsinized and seeded on 10cm dishes. They were further grown in media containing 
appropriate antibiotic for selection of transformed cells. Media was exchanged every 48h and 
after 14 days of selection, single cell colonies were picked and propagated for further 
analysis. Propagated positively selected cells were tested for expression of inserted coding 
sequences by Western analysis. 
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3.1.6. Inducing DNA damage by treating cells with ionizing radiation 
 MCF-7 cells were grown under standard culturing conditions. On the day of treatment 
cells on plates were transported in a closed Styrofoam box to the site of treatment. Cells were 
irradiated with 10 (for RNA sequencing experiments) or 6 (for colony formation assay) Gy of 
ionizing radiation using a cesium-137 γ-ray source. Cells were transported in a Styrofoam box 
to be placed back in the incubator and were cultured normally until they were used for 
analysis. 
3.1.7. Colony formation assay 
Colony formation assay was performed on MCF-7 cells after reverse transfection with 
appropriate siRNAs (section 3.1.3.) and mock transfected cells as negative control. Two 
batches of cells were prepared per transfection to test colony formation capabilities with and 
without treatment. Twenty-four hours after transfection cells grown in 6-well format were 
exposed to IR (section 3.1.5.), while control cells were left untreated. IR exposed and 
untreated cells were trypsinized and 1/32 volume of cell suspension was seeded in new 6-well 
plates. Cells were grown under standard conditions for two weeks. Afterwards media from the 
cells was removed and cells were washed with PBS. Cells were fixed for 2h in PBS 
containing 6.0% (v/v) glutaraldehyde and stained for 1h in PBS containing 0.5% w/v crystal 
violet. Stained colonies were counted using a stereomicroscope. Results of the clonogenic 
assay were analyzed with Microsoft Excel 2010. Average number of colonies from two 
biological replicates per each condition and each siRNA transfection, as well as standard 
deviation of the replicates were calculated. Statistical relevances of differences between 
numbers of colonies obtained with transfections with different siRNAs were calculated using 
student t-tests. 
3.1.8. UV cross-linking of human cells 
 Growth media was removed from HEK293 cells. Cells were washed in ice cold PBS 
and placed uncovered on a tray filled with ice. Tray with ice and cell plates were placed in 
Stratagene 1800 device and irradiated with 0.2 J/cm2 total energy of 254-nm UV light. After 
cross-linking cells were scraped off, suspended in ice cold PBS and centrifuged for 2 min at 
400 xg, 4°C. Supernatants were discarded and cells were used directly in downstream 
applications or flash frozen in liquid nitrogen and stored in -80°C for later use. 
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3.2. Biochemical methods 
3.2.1. Western analysis 
Protein samples were heated in SDS loading buffer for 5 min at 95 °C, and proteins 
were separated by SDS-PAGE using PageRuler Plus Prestained Protein Ladder or PageRuler 
Prestained Protein Ladder as size marker. Proteins from the polyacrylamide gel were 
transferred to nitrocellulose membranes (Thermo Fisher Scientific)  using the TransBlot 
Semi-dry Western Blot system (Bio-Rad) with 20 V for 60 min. Membranes were blocked for 
60 min at room temperature in blocking buffer (5% w/v powdered milk solution in TBS-T 
buffer) and subsequently incubated with primary antibody, diluted in blocking buffer, at 4°C 
overnight, with constant agitation. Membranes were washed 3x 10 min in TBS-T and 
incubated with HRP conjugated secondary antibodies diluted in blocking buffer for 60 min at 
room temperature. Membranes were washed 3x 10 min in TBS-T and protein signals were 
visualized by Amersham ECL Western Blotting Detection Reagent (GE healthcare) using 
ImageQuant LAS 4000 (Fujifilm). ImageQuant LAS 4000 software and ImageJ were used for 
image processing and analysis.  
3.2.2. Silver staining of proteins in polyacrylamide gels 
 Protein samples were heated in SDS loading buffer for 5 min at 95°C and separated by 
SDS-PAGE using PageRuler Plus Prestained Protein Ladder or PageRuler Prestained Protein 
Ladder as protein size marker. After electrophoresis gels were incubated in 50 ml Fixation 
Solution I for 1h at room temperature and then, in 50 ml Fixation Solution II overnight at 
room temperature. The next day, gels were washed 3 times in 50 ml sterile water and 
incubated 30 min in 50 ml Staining Solution. After the incubation gels were rinsed with sterile 
water and incubated in 50 ml Developer Solution until protein bands became clearly visible 
on the gel, then the reaction was stopped by addition of 5 ml of 50 mM EDTA. Solution was 
discarded and gels were rinsed with sterile water. Visualized proteins were observed, and gel 
images were taken using ImageQuant LAS 4000 (Fujifilm). 
3.2.3. RNA extraction 
 To isolate total RNA from cells, after removal of growth media, cells were lysed 
directly on plates with 1 ml of TRIzol reagent (Thermo Fisher Scientific) per 20 cm
2
 of 
growth surface. Lysates were transferred to tubes and mixed with 0.2 ml chloroform per 1 ml 
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of TRIzol used. Samples were separated into phases by centrifugation for 15 min at 12 000 g, 
4 ºC. Aqueous phase containing the RNA was moved to a new tube and mixed with 0.5 ml of 
isopropanol, per 1 ml of TRIzol used for cell lysis. Samples were incubated for 10 min and 
centrifuged for 15 min at 14 000 g, 4 ºC to pellet the RNA. Supernatant was discarded, RNA 
pellet was washed with 1 ml of 75% ethanol per 1 ml of TRIzol used for lysis. After removal 
of ethanol RNA pellets were air dried and resuspended in RNAse free water. RNA 
concentration was measured with Nanodrop and adjusted to around 200 ng/ml by addition of 
RNAse free water. 10X TURBO DNase buffer to 1X final concentration and 1 μl of TURBO 
DNAse (Thermo Fisher Scientific) per each 10 μg RNA were added to RNA samples and 
incubated at 37ºC for 30min. One sample volume of Phenol/Chloroform/ Isoamyl alcohol was 
mixed with samples and incubated for 5 min at room temperature. Samples were centrifuged 
to separate phases, aqueous phase was transferred to a new tube and mixed with 1/10 volume 
of 3 M NaCl solution and 1 volume of isopropanol. Samples were centrifuged for 15 min at 
14 000 g, 4ºC to pellet RNA. Pellets were washed with 1 ml of 75% ethanol, ethanol was 
removed, pellets air dried and resuspended in RNAse free water. RNA concentration was 
measured with Nanodrop and its integrity checked with agarose gel electrophoresis. 
 To isolate RNA from liquid samples 3 volumes TRIzol LS reagent (Thermo Fisher 
Scientific) was mixed with one volume of samples and incubated for 2 min at room 
temperature. Samples were mixed with 0.2 ml chloroform per 0.75 ml of TRIzol LS used. 
Samples were separated into phases by centrifugation for 15 min at 12 000 g, 4 ºC. The 
aqueous phase containing the RNA was transferred to a new tube and mixed with equal 
amount of isopropanol. Samples were incubated for 10 min and centrifuged for 15 min at 
14 000 g, 4 ºC to pellet the RNA. Supernatant was discarded, RNA pellet was washed with 1 
ml of 75% ethanol per 0.75 ml of TRIzol LS used. After removal of ethanol RNA pellets were 
air dried, resuspended in RNAse free water and used in subsequent analysis. 
3.2.4. First strand cDNA synthesis 
Up to 5 μg of RNA was mixed with 0.5 μl oligo(dT) primer (100 μM), 1 μl 10 mM 
dNTP mix and RNase free water to final volume of 14 μl. Mixtures were heated to 65ºC for 5 
min and incubated on ice for 1 min. Samples were briefly centrifuged and mixed with 4 μl 5X 
First-Strand Buffer, 1 μl 0.1 M DTT and 1 μl SuperScript III RT. Mixtures were incubated for 
5 min at 25ºC, then for 60 min at 50ºC and for 15 min at 70ºC. To remove RNA 
complementary to obtained cDNA from the sample, 1 μl (2units) of E. coli RNase H was 
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added with subsequent incubation at 37ºC for 20 min. Prepared cDNA was diluted with 
RNase-free water and used directly for downstream applications or stored in -20ºC. 
3.2.5. Real-Time quantitative PCR 
Real-Time quantitative PCR was performed with a StepOne System (Applied 
Biosystems) real-time PCR cycler and SYBR Green PCR Master Mix (Thermo Fisher 
Scientific) in two or three technical replicates for each biological replicate. 






Sybr Green Master Mix 2x 1x 
Forward primer 10 Mm 2 μM 
Reverse primer 10 Mm 2 μM 
Template 
depending on specific 
sample 
MiliQ water 
up to the final reaction 
volume 
 
Real-Time quantitative PCR reaction profile: 




95ºC 15 s 
x40 cycles 




95ºC 15 s 
slow heating 
(0.3ºC/s) 
60ºC 1 min 
95ºC 15 s 
 
Results from the qRT-PCR reaction were calculated in Microsoft Office Excel 2010 software.  
Relative transcript level  
First from technical replicates representing the same biological replicate (discarding at 
the same time results from technical replicates that were non-representative, when more than 
two technical replicates were performed) mean number of cycles needed for detection of 
product by the cycler was counted for GAPDH reference gene (x) and the target gene (y) in all 
investigated biological repeats. Next, obtained results were substituted into the formula 2^(x-
y)=z. Obtained result for investigated samples were divided by result obtained for control 
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samples. Means from two biological replicates were calculated. Standard deviation of results 
obtained for biological replicates was calculated with Excel STDEV function. 
Fold enrichment of pulled-down HULC transcript 
First, from technical replicates representing the same biological replicate mean number 
of cycles needed for detection of product by the cycler was counted for the positive sample 
(x) and the negative control sample (y). Next, obtained results were substituted into the 
formula 2^-(x-y)=z. Means from two biological replicates were calculated. Standard deviation 
of results obtained for biological replicates was calculated with Excel STDEV function. 
Percentage of HULC transcript eluted in pull-down experiment 
First from technical replicates representing the same biological replicate mean number 
of cycles needed for detection of product by the cycler was counted for transcripts eluted with 
imidazole buffer (x) and for transcripts eluted with subsequent Proteinase K treatment (y). 
Next, obtained results were substituted into the formula: 2^x/(2^x+2^y)*100=z to calculate 
percentage of transcript eluted with imidazole and 2^y/(2^x+2^y)*100=z to calculate 
percentage of transcript subsequently eluted with Proteinase K. Means from two biological 
replicates were calculated. Standard deviation of results obtained for biological replicates was 
calculated with Excel STDEV function. 
Percentage of input Csy4 transcript pulled-down from input sample 
Initially, from technical replicates representing the same biological replicate mean 
number of cycles needed for detection of product by the cycler was counted for the input 
sample (x) and the pull-down sample (y). X was adjusted by subtracting an appropriate 
amount of cycles representing the difference between percent of total input sample used and 
the percent of total pull-down sample used (a). For example if 1% of input sample and 100% 
of pull-down sample were used 6.644 cycles were subtracted from x. Next, obtained results 
were substituted into the formula 100*2^(a-y)=z. Means from two biological replicates were 
calculated. Standard deviation of results obtained for biological replicates was calculated with 
Excel STDEV function. 
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3.2.6. Csy4 mediated RNA pull-down 
3.2.6.1. RNA pull-down with in-vitro purified Csy4 
Preparation of biotinylated Csy4 mutant protein 
One mg of recombinant in-vitro purified Csy4 protein (a kind gift from the Meister 
laboratory, University of Regensburg) was mixed with biotinylation buffer to final volume of 
455 μl. Then 45 μl 10 mg/ml EZ-Link maleimide-PEG2-biotin was added and samples were 
incubated overnight at room temperature. After biotinylation, protein was dialyzed using 
Slide-A-Lyzer Dialysis Cassette Kit (Thermo Fisher Scientific) to remove free maleimide-
PEG2-biotin. First, cassettes were hydrated in PBS buffer for 2 min, then all of the Csy4 
sample was applied to the cassette with a syringe and cassettes were incubated in 1000 ml of 
PBS overnight at 4ºC. Csy4 protein was removed from the dialysis cassette, aliquoted with 
final concentration of glycerol 50% and stored in -80ºC for further use. 
Cellular lysis and preparation of input sample 
Mock transfected cells and cells transfected with plasmids expressing HULC lncRNA 
tagged with Csy4 target stem loop on the 5’ transcript end (section 3.1.4.) were UV cross-
linked and lysed with 3 cell pellet volumes of NP-40 lysis buffer (containing complete 
EDTA-free protease inhibitor cocktail and 0.5 mM DTT) and incubated on ice for 10 min. 
Cellular debris was pelleted by centrifugation at 12 000 xg for 15 min at 4ºC. Supernatants 
were transferred to new RNase free tubes and 10% of the lysate from each sample was saved 
in a separate tube for later analysis. 
Enrichment for HULC RNA from the lysate 
3 pmol of biotinylated Csy4 protein was added per each 100 μl of cell extract. As a 
negative control equal volume of lysate was used without addition of Csy4. Mixtures were 
incubated for 1.5h on rotating wheel at 4ºC. Then, 0.7 μl of M-280 Streptavidin Dynabeads 
(Thermo Fisher Scientific) for every 100 μl of cellular extract was prepared by washing twice 
with 1 ml of NP-40 lysis buffer and mixed with the Csy4 incubated lysate and negative 
control sample. The mixtures were incubated for 1h on rotating wheel at 4ºC. Beads were 
concentrated on a magnet, cellular extracts were discarded and beads were washed three times 
in NP-40 lysis buffer containing proteinase inhibitors and 0.5 mM DTT. For each wash, beads 
were incubated with the buffer for 5 min at 4ºC on a rotating wheel. After the second wash, 
beads were transferred to fresh RNase-free tubes and the third wash was performed. 
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Subsequent steps of the protocol differ depending on which parameters of the pull-down 
approach were being assayed.  
Initial test of successful HULC enrichment 
Beads from Csy4 preincubated and negative control samples were mixed with 100 μl 
of 1x Proteinase K buffer and Proteinase K to final concentration of 2 mg/ml. Input samples, 
which were put aside in initial step of the protocol were mixed with 1 volume of 2x Proteinase 
K buffer and Proteinase K to final concentration of 2 mg/ml. Then, beads and input samples 
were incubated in 40ºC for 1h and mixed with three volumes of Trizol LS reagent and RNA 
extraction was performed (section 3.2.3.). Obtained RNA was subjected to reverse 
transcription (section 3.2.4.) and analyzed with RT-qPCR (section 3.2.5.) to compare 
enrichment of HULC RNA. 
Test of imidazole driven elution from beads 
After confirmation of successful target transcript enrichment described above, 
efficiency of imidazole driven elution was tested. Enzymatic activity of Csy4 mutant protein 
may be restored in presence of imidazole. This mode of elution has been shown to provide 
increased specificity when compared to traditional elution methods (Lee et al., 2013). 
After enrichment for HULC RNA from the lysate, beads were first incubated with 50 
μl of Csy4 Elution Buffer at 4ºC, overnight. Eluates were taken to fresh RNase-free tubes and 
mixed with 50 μl of 2x Proteinase K buffer and Proteinase K to final concentration of 1 
mg/ml. To remaining beads 100 μl of 1x Proteinase K buffer and Proteinase K to final 
concentration of 1mg/ml were added. Both samples were incubated at 40ºC for 30 min. Then, 
mixed with three volumes of TRIzol LS reagent and RNA extraction was performed (section 
3.2.3.). Obtained RNA was subjected to reverse transcription (section 3.2.4.) and analyzed 
with RT-qPCR (section 3.2.5.) to assay the fraction of the transcript eluted with imidazole and 
fraction of the transcript eluted with subsequent Proteinase K treatment. 
Test of method specificity and efficiency 
After confirmation of satisfactory efficiency of imidazole driven elution, subsequent 
experiments were performed with this mode of elution after enrichment for HULC RNA from 
the lysate. To test the specificity of the method, eluates and input samples were split in two, 
and one half was subjected to Proteinase K treatment and TRIzol LS extraction to analyze 
associated transcripts with qRT-PCR. Second half of samples was mixed with 25 mM MgCl 
to a final concentration of 2 mM and with 1 μl of Benzonase, then incubated at 37ºC for 30 
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min, boiled in SDS loading buffer at 95ºC for 5 min and used for analysis with Western 
blotting (section 3.2.1.) or Silver Staining (section 3.2.2.).  
3.2.6.2. RNA pull-down with Csy4 expressed in human cells 
Determination of successful expression of Csy4 
HEK293 cells were transfected with plasmids coding for human codon optimized 
Csy4 protein N-end fused with FLAG/HA or STREP/HA epitopes, with its mRNA tagged 
with different number of repeats of Csy4 target stem loops in the 3’ UTR (section 3.1.4.). 
Expression of Csy4 from the plasmids was assayed with Western analysis (section 3.2.1.). 
Satisfactory expression was only achieved with constructs expression STREP/HA version of 
the protein, which were used in subsequent experiments. 
Cellular lysis and preparation of input sample 
UV cross-linked HEK293 cells expressing human codon optimized Csy4 protein 
tagged with STREP/HA, with its mRNA tagged with different number of repeats of Csy4 
target stem loops in the 3’ end (section 3.1.4.) were subjected to cellular lysis and preparation 
of input sample in the same way as described section 3.2.6.1.  
Enrichment for Csy4 mRNA from the lysate 
One μl of MagStrep XT beads (Iba Life Sciences) for every 100 μl of cellular extract 
was prepared by washing twice with 1 ml of NP-40 lysis buffer and mixed with the lysate. 
The mixture was incubated for 1h on rotating wheel at 4ºC. Beads were concentrated with 
Dynal MPC-S magnetic particle concentrator, cellular extracts were discarded and beads were 
washed three times in Strep Tactin Wash Buffer. For each wash, beads were incubated with 
the buffer for 5 min at 4ºC on a rotating wheel. After the second wash beads were moved to 
fresh RNase-free tubes and the third wash was performed.  
Elution of proteins and RNAs and test of method specificity and efficiency 
To elute RNAs beads were mixed with 100 μl of 1x Proteinase K buffer and 
Proteinase K to final concentration of 2 mg/ml. Input samples, which were put aside in the 
initial step of the protocol were mixed with 1 volume of 2x Proteinase K buffer and 
Proteinase K to final concentration of 2 mg/ml. Then, beads and input samples were incubated 
in 40ºC for 1h and mixed with three volumes of Trizol LS reagent and RNA extraction was 
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performed (section 3.2.3.). Obtained RNA was subjected to reverse transcription (section 
3.2.4.) and analyzed with qPCR (section 3.2.5.) to compare enrichment of Csy4 mRNA. 
To elute proteins beads were mixed with 1x SDS loading buffer containing 2 mM 
MgCl2 and proteinase inhibitors and with 1 μl of Benzonase. Input samples, which were put 
aside in the initial step of the protocol were mixed with 1 volume of 2x SDS loading buffer 
containing 4 mM MgCl2 and proteinase inhibitors and with 1 μl of Benzonase. Then, beads 
and input samples were incubated at 37ºC for 30 min, boiled in SDS loading buffer at 95ºC 
for 5 min and used for analysis with Western blotting (section 3.2.1.). 
3.2.7. RNA library preparation and sequencing 
3.2.7.1. Preparation of polyadenylated RNA fraction 
RNA samples were subjected to enrichment for polyadenylated transcripts with Oligo 
(dT)25 Dynabeads. 75μg of RNA was diluted to 100 μl volume with 10mM Tris-HCl pH 7.5 
and 100 μl of Binding Buffer was added. Mixtures were incubated in 65ºC for 2 min and 
placed on ice. 1 mg of Oligo (dT)25 Dynabeads was placed in a RNase-free tube, washed 
once with Binding Buffer and placed on a magnet. Supernatants were discarded and RNA was 
added to the beads. Samples were mixed and incubated for 5 min at room temperature on a 
rotating wheel. Tubes were placed on a magnet for 2 min and supernatants were removed. 200 
μl of Washing Buffer B was added to the beads and samples were mixed by pipetting. Tubes 
were placed on the magnet and supernatants removed. Wash with Buffer B was performed 
twice. To elute bead bound RNA 100 μl of 10 mM Tris-HCl was added and samples were 
incubated at 80ºC for 2 min. Then, tubes were placed on a magnet and supernatant containing 
eluted RNA was quickly moved to a new tube. The selection for polyadenylated RNAs was 
performed one more time on eluted transcripts in the same way, with a difference of elution 
step, which was performed in 20 μl Tris instead of 100 μl. Concentration of obtained RNA 
was measured with Nanodrop and its integrity checked with agarose gel electrophoresis. 
3.2.7.2. Depletion of polyadenylated RNA 
RNA samples were subjected to depletion of polyadenylated transcripts with Oligo 
(dT)25 Dynabeads. 75μg of RNA was diluted to 100 μl volume with 10mM Tris-HCl pH 7.5 
and 100 μl of Binding Buffer was added. Mixtures were incubated in 65ºC for 2 min and 
placed on ice. 1 mg of Oligo (dT)25 Dynabeads was placed in a RNase-free tube, washed 
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once with Binding Buffer and placed on a magnet. Supernatants were discarded and RNA was 
added to the beads. Samples were mixed and incubated for 5 min at room temperature on a 
rotating wheel. Tubes were placed on a magnet for 2 min and supernatants were moved to a 
new RNase-free tube. Then, a second round of depletion was performed as described above. 
Supernatants after second round of depletion were mixed with 1/10 volume of 3M NaCl and 1 
volume of isopropanol. Samples were centrifuged for 30 min at 20 000 g, 4ºC to pellet RNA. 
Liquid was removed from the pellets, they were air dried and resuspended in 50 μl of RNase 
free water. 
3.2.7.3. Depletion of ribosomal RNA 
RNA samples were depleted of ribosomal RNAs with Ribo-Zero Gold Kit 
(Human/Mouse/Rat) from Illumina. 
Per each sample, 225 μl of beads from the kit was placed in a RNase-free tube. Tubes 
were placed on a magnet and supernatants were removed from the beads. Beads were washed 
twice with 225 μl of RNase-free water and resuspended in 65 μl of Magnetic Bead 
Resuspension Solution by vortexing. Then, 1 μl of RiboGuard RNase Inhibitor was added to 
the beads. 
Per each depletion reaction up to 5 μg of RNA was mixed with 4 μl Ribo-Zero rRNA 
Reaction Buffer, 10 μl Ribo-Zero Removal Solution and RNase-free water to final volume of 
40 μl. Mixtures were incubated at 68ºC for 10 min. Then tubes were briefly centrifuged and 
incubated at room temperature for 5 min. RNA samples were next added to the resuspended 
beads and immediately mixed by pipetting. Then, samples were vortexed for 15 s and 
incubated at room temperature for 5 min. Tubes were open and placed on a magnet. 90 μl of 
supernatant was carefully removed and placed in a new RNase-free tube. Samples were mixed 
with 10 μl of 3M NaAc and 1.5 μl Glycogen. Then, 300 μl of 100% ethanol was mixed with 
the samples, which were next incubated at -80ºC for 2h. RNA was pelleted by centrifugation 
for 1h at 20 000 g, 4ºC. Supernatants were removed from RNA pellets, which were then air 
dried and resuspended in RNase-free water.  
3.2.7.4. Preparation of stranded RNA libraries 
Stranded RNA sequencing library were produced using the NEXTflex Directional 
RNA-Seq Kit V2 (Bioo Life Science). 
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To fragment RNA 100 ng of RNA per sample was mixed with 5 μl of NEXTflex RNA 
Fragmentation buffer and RNase-free water to a final sample volume of 19 μl. Samples were 
incubated at 95ºC for 10 min and immediately after placed on ice. To each sample, 1 μl of 
NEXTflex First Strand Synthesis Primer was added and incubated for 5 min at 65ºC. Samples 
were placed on ice and mixed with 1 μl of SuperScript III RT and 4 μl of NEXTflex 
Directional First Strand Synthesis Buffer Mix. To synthesize first strand of cDNA mixtures 
were incubated in a thermocycler first at 25ºC for 10 min, then 50ºC for 50 min and at 70ºC 
for 15 min. For second cDNA strand synthesis samples were mixed with 25 μl of NEXTflex 
Directional Second Strand Synthesis Mix and incubated at 16ºC for 60 min. 
Next, nucleic acids were purified with AMPure XP Beads (Beckman Coulter). 90 μl of 
beads was mixed with each sample and mixtures were incubated at room temperature for 5 
min. Beads were concentrated on a magnet and supernatants were discarded. Concentrated 
beads were washed twice by incubating with 200 μl of 80% ethanol. After ethanol was 
removed tubes were removed from the magnet and air dried for 2 min. Beads were 
resuspended in 17 μl Resuspension Buffer and incubated for 2 min in room temperature. 
Tubes were placed again on a magnet and beads were concentrated for 5 min. 16 μl of 
supernatants was moved to new tubes. Adenylation of nucleic acids was performed by mixing 
samples with 4.5 μl of NEXTflex Adenylation Mix and incubation in a thermocycler at 37ºC 
for 30 min and then 70ºC for 5 min. To ligate adapters samples were mixed with 27.5 μl 
NEXTflex Ligation Mix and 2 μl NEXTflex RNA-Seq Barcode Adapter (different barcode 
was used for each sample). Samples were incubated at 30ºC for 10 min and reaction products 
were purified with AMPure XP Beads. 50 μl of beads were mixed with each sample and 
incubated at room temperature for 5 min. Beads were concentrated on a magnet for 5 min and 
supernatants were removed. Concentrated beads were washed twice by incubating with 200 μl 
of 80% ethanol twice. After ethanol was removed tubes were removed from the magnet and 
air dried for 2 min. Beads were resuspended in 51 μl of Resuspension Buffer and incubated at 
room temperature for 2 min. Samples were placed again on a magnet for 5 min and 
supernatants were moved to new tubes. The whole bead purification procedure was repeated 
ending with elution of nucleic acids from the beads with 36 μl Resuspension Buffer and 
transferring 35 μl of supernatants to new tubes. 
To PCR amplify obtained nucleic acids samples were mixed with 1 μl NEXTflex 
Uracil DNA Glycosylase, 12 μl NEXTflex PCR Master Mix and 2 μl NEXTflex Primer Mix 
and subjected to a reaction with a following profile: 
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37 30 min 
 98 2 min 
 98 30 s 
 65 30 s Repeat 15 cycles 
72 60 s 
 72 4 min 
  
PCR products were purified with AMPure XP Beads. Purification was performed as 
described above for total of 2 rounds of purification. First purification was performed with 40 
μl of beads and elution with 51 μl of Resuspention Buffer, second with 40 μl of beads and 
elution with 32 μl of the buffer. 
3.2.7.5. Preparation and sequencing of metabolically labeled RNA ftaction 
 Cells were grown in Q-medium containing 1 nM 4-sU for 5 min prior to RNA 
extraction with TRIzol reagent (section 3.2.3.). 70 μg of RNA per sample was mixed with 3.5 
μg of D. melanogaster 4-sU labelled RNA, to provide internal control for quantification in 
analysis of the data generated in the experiment. RNA mixtures were biotinylated using 
MTSEA biotin-XX (Biotium). Reaction mixtures were containing 73.5 μg RNA, 10 mM 
HEPES (pH7.5), 1 mM EDTA, and 5 μg of the biotin in total volume of 250 μl. Samples were 
incubated for 30 min at room temperature in the dark.  
After biotinylation samples were mixed with one sample volume of 
Phenol/Chloroform/ Isoamyl alcohol and incubated for 5 min at room temperature. Samples 
aqueous phases were recovered using Phase-Lock-Gel tubes (5PRIME) and RNA was 
precipitated using 1/10 sample volume 3M NaCl and 1 sample volume of isopropanol. RNA 
was pelleted by centrifugation at 20 000 xg, 4ºC. Pellets were washed with 1 ml of 75% 
ethanol, ethanol was removed, pellets air dried and resuspended in 50 μl RNAse free water. 
RNA was incubated at 65ºC for 10 min and fallowed by incubation on ice for 5 min. 
Biotinylated RNA was isolated from the samples using μMACS Streptavidin MicroBeads 
(Miltenyi). 200 μl of beads was added to each sample and incubated at room temperature for 
15 min. Next, μColumns were placed on the μMACS magnetic separator and were 
equilibrated with nucleic acid wash buffer. RNA-beads mixtures were appliead to the columns 
and flow throughs were discarded. Then, the columns were washed twice with 500 μl of warm 
High Salt Wash Buffer. 4-sU labelled RNA was eluted from the columns in two rounds, each 
with 100 μl of freshly prepared 100 mM DTT. Eluted RNA was purified using MinElute Spin 
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columns (Qiagen) according to manufacturer’s instructions. Obtained RNA samples were 
measured with Qubit 2.0 Fluorometer (Invitrogen). 
Entirety of obtained samples was subjected to depletion of rRNAs with Ribo-Zero 
Gold Kit (section 3.2.6.3.), fallowing preparation of sequencing libraries with TruSeq 
Stranded Total RNA Library Prep Kit (Illumina), according to manufacturer’s instructions. 
3.2.7.6. High Throughput Next Generation Sequencing 
RNA libraries were first quantified with Qubit 2.0 Fluorometer (Invitrogen) and 
libraries from the same experiment were pooled together in equimolar ratios. Pooled libraries 
were analyzed with Agilent High Sensitivity DNA chip and submitted with results of the 
analyzes to Genomics Core Facility at MDC, which performed the sequencing reactions. 
3.2.8.  Ribosome profiling 
The protocol for Ribosome profiling was adapted from Ingolia et al., 2009.  
Cell harvesting and lysis 
Flp-In T-REx HEK293 cells grown on 10cm plates, transfected with control siPool 
and with DDX3 targeting siPool were washed with 5 ml of PBS containing 100 μg/ml 
cyclohexamide, flash frozen on liquid nitrogen, kept on dry ice, lysed in 150 μl of 
Mammalian Polysome Lysis buffer, transferred to wet ice and harvested to RNase-free tubes. 
Next, with syringes lysates were squeezed up and down through 26G needles 20 times and 
cleared by centrifugation at 20 000 xg for 5 min in 4ºC. Supernatants were transferred to new 
tubes, aliquoted and stored at -80ºC. Levels of DDX3 protein in the lysates were checked with 
Western analysis before continuing with the experiment. 
mRNA library preparation for normalization of ribosome profiling data 
 To determine the abundance of mRNA in ribosome profiling, necessary for 
normalization of data and its proper analysis, an aliquot of a lysate per sample was subjected 
to RNA extraction with TRIzol LS reagent (section 3.2.3.). Extracted RNA was used for 
mRNA library preparation using TruSeq Stranded mRNA Library Prep Kit (Illumina) 
according to the manufacturer’s protocol. 
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RNA digestion, monosome purification and RNA extraction 
Thawed lysates were treated with RNase I at a final concentration of 2.5 U/μl for 45 
min at room temperature with slow agitation. Further RNase activity was stopped by addition 
of 8 μl SUPERase In (20 U/μl) per 240 μl of lysate. Next, Illustra MicroSpin Columns S-400 
HR were equilibrated with 3 ml of Mammalian Polysome Buffer, centrifuged 600 xg for 4 
min at 4ºC, moved to RNase-free tubes and used to enrich for ribosome complexes. After the 
lysates entered the columns, they were centrifuged 600 xg for 2 min at 4ºC. To extract RNA 
from the flow through, samples were mixed with 3 volumes of TRIzol LS reagent, incubated 
for 10 min at room temperature, then mixed with 1/5 sample volume of chloroform, incubated 
again at room temperature for 3 min and centrifuged 15 000 xg for 15 min at 4ºC. RNA from 
aqueous phase of samples was purified and concentrated with Zymo-Spin IIC columns. 
Purified nucleic acids were eluted from the columns with 30 l of MiliQ water and their 
concentration was measured with Nanodrop.  
rRNA depletion and gel purification of ribosome footprints 
Five g of RNA per sample were used for rRNA depletion with Ribo-Zero Gold Kit 
(section 3.2.6.3.). Next, samples and two size markers 27 and 30 nt long were mixed with 
Formamide Loading Buffer, incubated at 95 ºC for 30 sec and separated in 17% Urea gels 
runned at 30W for 90 min using Owl Vertical Electrophoresis Systems (Thermo Fisher 
Scientific). The gel was stained in 120 ml of 1:10 000 SYBR Gold solution in 1x TBE buffer 
for 40 minutes with slow agitation and nucleic acids were observed with ImageQuant LAS-
4000. Slices corresponding to ribosome footprints in each sample (between 27 and 30 nt), as 
well as 27 and 30 nt were excised from gel. Gel slices were eluted by incubation with 350 μl 
of 0.3M NaCl solution per slice overnight at 4ºC with shaking at 1 200 RPM. Maximum 
possible amount of liquid was transferred from tubes containing gel slices to new tubes and 
precipitated by addition of 1 μl Glycoblue and 3 volumes of 100% EtOH. Samples were 
centrifuged at 20 000 xg for 1 h in 4ºC to pellet nucleic acids. Supernatants were removed, 
pellets were air dried and resuspended in 19 μl of MiliQ water. 
PNK treatment and purification 
To resuspended nucleic acids 5 μl of 10x PNK Buffer, 0.5 μl 0.1 M DTT, 0.5 μl 100 
mM ATP, 0.5 μl 10% Triton X-100, 2 μl PNK and 22.5 MiliQ water was added and samples 
were incubated 37ºC for 30 min. Next, 150 μl of MiliQ water, and 200 μl of 
phenol/chloroform/isoamylalcohol was added to the samples, which were then vortexed and 
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centrifuged at 13 000 xg for 2 min at 4ºC. Aqueous phase was moved from samples to new 
tubes, mixed with 20 μl of 3M NaCl and 1 μl of Glycoblue and precipitated with 3 volumes of 
100% EtOH. Nucleic acids were pelleted by centrifugation at 20 000 xg for 1 h at 4ºC. 
Supernatants were removed, pellets were air dried and resuspended in 6 μl of MiliQ water. 
3’ adapter ligation and gel purification of adapter-ligated fragments 
Resuspended 27 and 30 nt size markers were mixed together and split in two tubes. To 
all samples 2 μl 10x RNA ligase buffer, 10 μl 50% PEG-8000 and 1 μl 50 μM pre-adenylated 
3’ adapter were added. Samples were mixed by pipetting, denatured at 95ºC for 30 sec and 
kept on ice for 5 min. Next, to all samples, except for one of the tubes containing combined 
size markers (used as unligated control) 1 μl T4 RNA ligase 2, K227Q truncated was added. 
All samples were incubated for 16 h at 16ºC with slow agitation. Samples were mixed with 20 
μl 2x Formamide Loading Buffer and denatured at 95ºC for 30 sec and RNA was separated in 
15% Urea gel run at 30W for 90 min using Owl Vertical Electrophoresis Systems (Thermo 
Fisher Scientific). The gel was stained in 120 ml of 1:10 000 SYBR Gold solution in 1x TBE 
buffer for 40 minutes with slow agitation and nucleic acids were observed with ImageQuant 
LAS-4000. Slices corresponding to RNA fragments ligated to 3’ adapters were excised from 
the gel. Gel slices were eluted by incubation with 350 μl of 0.3M NaCl solution per slice over 
night at 4ºC with shaking at 1 200 RPM. Maximum possible amount of liquid was transferred 
from tubes containing gel slices to new tubes and precipitated by addition of 1 μl Glycoblue 
and 3 volumes of 100% EtOH. Samples were centrifuged at 20 000 xg for 1 h in 4ºC to pellet 
nucleic acids. Supernatants were removed, pellets were air dried. 
5’ adapter ligation and gel purification of adapter-ligated fragments 
Nucleic acid pellets were resuspended directly in 5 μl MiliQ water, 2 μl 10x RNA 
ligase buffer, 2 μl DMSO, 2 μl 10 nM ATP, 0.5 μl 100 μM 5’ adapter. Next, 7.5 μl of 50% 
PEG-8000 was added and samples were mixed by pipetting. Samples were denatured at 95ºC 
for 30 sec and incubated on ice for 5 min. Samples containing size markers were split in two 
to serve as ligated and unligated size controls. 1 μl T4 RNA ligase 1 was added to all samples 
except for the unligated size control and all were incubated in thermos block for 2 h at 37ºC, 
shaking at 500 RPM. Samples were mixed with 1 volume of 2x Formamide Loading Buffer 
and denatured at 95ºC for 30 sec and RNA was separated in 15% Urea gel run at 30W for 90 
min using Owl Vertical Electrophoresis Systems (Thermo Fisher Scientific). Gel was stained 
in 120 ml of 1:10 000 SYBR Gold solution in 1x TBE buffer for 40 minutes with slow 
agitation and nucleic acids were observed with ImageQuant LAS-4000. Slices corresponding 
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to RNA fragments ligated to 3’ adapters were excised from gel. Gel slices were eluted by 
incubation with 350 μl of 0.3M NaCl solution per slice over night at 4ºC with shaking at 
1.200 RPM. Maximum possible amount of liquid was moved from samples containing gel 
slices to new tubes and precipitated by addition of 1 μl Glycoblue and 3 volumes of 100% 
EtOH. Samples were centrifuged at 20 000 xg for 1 h in 4ºC to pellet nucleic acids. 
Supernatants were removed, pellets were air dried. 
Reverse Transcription and PCR amplification 
 RNA pellets were used in a reverse transcription reaction (section 3.2.4.), with all 
ingredients of the reaction scaled down to final reaction volume of 15 μl. Resulting cDNA 
samples were diluted to a final volume of 80 μl, with RNase-free water. For PCR 
amplification 30 μl of resulting cDNA sample was mixed with 30 μl 5x Phusion Buffer, 3.75 
μl 10 mM dNTPs, 0.75 μl 100 μM RPI1 primer, 0.75 μl 100 μM RPI reverse primer (with 
barcode), 1.5 μl Phusion DNA Polymerase and 83.25 μl RNase-free water. Mixtures were 
subjected to a PCR reaction with a following profile:  
98 40 s 
 98 10 s 
 65 30 s Repeat 15 cycles 
72 15 s 
 72 5 min 
  
PCR were precipitated with 450 μl ethanol at -20ºC and DNA was pelleted by centrifugation 
for 30 min at 13 000 g, 4ºC. DNA pellets were dried and resuspended in 25 μl of RNse-free 
water. 5 μl 6x DNA Loading Dye was mixed with each sample and nucleic acids were 
separated on 2.5% Low Melting agarose gel, with SYBR gold. DNA bands were visualized 
using a UV-transilluminator and PCR amplicons of the right size were excised and purified 
using Zymo Gel Purification Kit (Zymo Research). 
3.2.9. Analysis of High-Throughput sequencing results 
 Sequencing results obtained from MCF-7 cells were converted into fastq files by N. 
Kastelic or M. Milek using cassava software at the host institute. Data was demultiplexed 
using Flexbar software (Dodt et al., 2012) and mapped to genome annotation with TopHat 
(Trapnell et al., 2012). Analysis of differential gene expression was performed using 
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SeqMonk (https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/) and DESeq2 
(Love et al., 2014) software. 
 Analysis of sequencing results for differential expression of circRNAs was performed 
by Petar Glazar from Rajewsky laboratory at the host institution. 
 Analysis of ribosome profiling sequencing results (ribosome footprints and mRNA 
abundance) was performed by Lorenzo Calviello from University of California, San Francisco 
(UCSF). 
 Analysis of sequencing results of 4-sU labeled fractions of RNA (section 3.2.7.5.) was 
performed by Vedran Franke from the laboratory of Altuna Akalin, using an improved 
version of the antisense transcript detection algorithm introduced in Wyler et al., 2017. 
3.2.9. Molecular cloning 
 Sequence of Csy4 target stem loop (Lee et al., 2013) was ordered as two partially 
complementary oligonucleotides (section 2.3), which were hybridized and subjected to 
reaction with High Fidelity Phusion polymerase (Thermo Fisher Scientific) to obtain a double 
stranded product and was cloned to appropriate plasmids with standard restriction enzyme 
based cloning procedure. 
 HULC transcript was amplified from HEK293 derived cDNA with PCR using 
appropriate primers (section 2.3) and cloned to pcDNA5/FRT/TO plasmid background using 
restriction enzyme cloning. Resulting plasmid was used for further cloning with restriction 
enzymes to insert Csy4 target stem loop sequence to the 3’ end HULC sequence. 
 Human codon optimized Csy4 mutant protein DNA sequence was cloned using 
restriction enzymes from pEX-Csy4 plasmid to pRNTR4 plasmid background. Resulting 
plasmid was used for further cloning with restriction enzymes to insert Csy4 target stem loop 
sequence to the 5’ UTR of Csy4 sequence between the STOP codon and polyadenylation 
signal. Additional Csy4 target stem loop sequences were added to resulting plasmid with 
restriction enzyme cloning resulting in versions containing 1, 2 and 4 stem loop sequences. 
Obtained plasmids containing various number of Csy4 target stem loops were cloned to 
pFRT/TO/DEST/FLAG/HA and pFRT/TO/DEST/STREP/HA plasmid backgrounds with 
Gateway LR Clonase (Thermo Fisher Scientific). 
 DDX3 homology arms were cloned using restriction enzymes from pEX-DDX3HA to 
pHR110-mAIDHA-RFP and pHR510-mAIDHA-RFP-T2A plasmid backgrounds. 
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 Sequences of guide RNAs targeting to genomic sequence in close proximity to DDX3 
stop codon were ordered as pairs of partially complementary oligonucleotides (section 2.3), 
hybridized and cloned into px458 plasmid background. 
3.2.10. Rapid Amplification of cDNA Ends 
3’ RACE was performed with 3' RACE System for Rapid Amplification of cDNA Ends kit 
(Thermo Fisher Scientific), using RNA isolated with TRIzol Reagent (section. 3.2.3.) from 
MCF-7 cells 16h after exposure to 10 Gy of IR.  
Synthesis of First Strand cDNA with 3’ adaptor sequence 
5 μg of total RNA was mixed with RNase-free water to a final volume of 11 μl, 1 μl of 10 μM 
Adapter Primer solution was added, mixtures were incubated at 70ºC for 10 min and kept on 
ice for 1 min. Samples were centrifuged briefly and mixed with 2 μl 10X PCR buffer, 2 μl 25 
mM MgCl2, 1 μl 10 mM dNTP mix and 2 μl 0.1 M DTT. Samples were briefly centrifuged 
again, mixed with 1 μl SuperScript II room temperature and incubated at 42ºC for 50 min. To 
terminate the reaction samples were heated to 70ºC for 15 min and cooled on ice. Samples 
were mixed with 1 μl of RNase H and incubated at 37ºC for 20 min. 
Amplification of the target cDNA 
To amplify the 3’ ends of transcript of interest 2 μl of cDNA was mixed with 5 μl 10X PCR 
buffer, 3 μl 25 mM MgCl2, 1 μl 10 mM dNTP mix, 1 μl of appropriate gene specific primer 
(section 2.3), 1 μl Universal Amplification Primer 0.5 μl Taq DNA polymerase and 36.5 μl 
RNase-free water. PCR reaction was performed with a standard program for Taq polymerase. 
with annealing temperature 60 ºC and extension time 2 min. PCR products were size 
separated with agarose gel electrophoresis, using ethidium bromide and GeneRuler 1kb DNA 
ladder. Observed amplicons were excised from the gel, purified with QIAquick Gel 
Extraction Kit (Qiagen) and cloned to pJET1.2 vector background, with CloneJET PCR 
Cloning Kit (Thermo Fisher Scientific). Plasmids obtained in the cloning procedure were used 
for bacterial transformation, bacteria were grown on agar plates with appropriate antibiotic 
selection and used in downstream analysis. 
Identification of amplified 3’ cDNA ends. 
Plasmids from three bacterial colonies per each cloned 3’ cDNA end were isolated with 
QIAprep Spin Miniprep Kit (Qiagen) and send for separate sanger sequencing reactions with 
pJET1.2 forward and reverse sequencing primers. Obtained sequences were compared with 
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known sequences of lncRNAs of interest available at https://lncipedia.org/, sequences of 






4.1. Development of new RNA pull-down methodology 
Quantitative determination of in vivo RNP composition is challenging. This is largely 
due to low sensitivity and specificity of existing methods to detect proteins interacting with a 
single RNA transcript of moderate to low expression level. We have addressed the need for a 
method which allows quantitative determination of in-vivo RNP composition combined with 
ease of use. Therefore, we based the development of new biochemical method on the Csy4 
protein to specifically isolate a single RNA transcript from complex mixtures such as cell 
lysates. Csy4 is an endoribonuclease from Pseudomonas aeruginosa involved in CRISPR 
RNA processing. In bacteria it binds to a specific 16-nt long stem loop structure and cleaves 
the RNA at the base of the stem loop. The protein has been shown to have markedly higher 
affinity than that of molecules previously used for in-vivo RNA pull-down approaches 
(Stockley et la., 1995; Sternberg et al., 2012; Leppek and Stoecklin 2013). We have reasoned 
that this feature of Csy4 makes it a good candidate for design of RNA pull-down 
methodology that may outperform existing approaches. The utilization of Csy4 for RNA pull-
down is possible thanks to development of a catalytically inactive version of this protein, 
which allows stable binding to the target stem loop without subsequent cleavage. The 
catalytic activity of the protein can be rescued in the presence of imidazole (Lee et al., 2013). 
This version of Csy4 has been successfully used for development of an in-vitro RNA pull 
down method (Fig. 1A). In order to attempt combining high efficiency with ease of use as 
well as to capture in-vivo RNA-protein interactions, we developed an experimental setup 
utilizing recombinant Csy4. 
 We have developed two different approaches of Csy4 mediated in-vivo RNA pull-
down. In the first one the transcript of interest is tagged with Csy4 target stem loop and 
expressed in cells. Interactions between the transcript and its associated proteins take place in 
living cells and can be preserved by the formation of covalent protein-RNA cross-links 
facilitated by UV irradiation. Cells are lysed and target transcript is enriched for with in-vitro 
purified, tagged Csy4 conditional enzyme (Fig. 1B). In the second approach both the stem 
loop tagged transcript of interest and tagged Csy4 mutant protein are expressed in cells. RNA-
protein interactions are preserved by cross-linking, cells are lysed and Csy4-hairpin-RNP 





Figure 1. Graphic representation of Csy4 based pull-down strategies. A – Scheme of in-vitro 
Csy4-based RNA affinity purification. Avidin agarose, biotinylated Csy4, and Csy4 hairpin-
tagged transcript are preincubated to make a ternary complex, which is then incubated with 
uncross-linked cell extract. After washing, the RNA–protein complexes are eluted by cleaving 
the Csy4 hairpin tag and releasing RNA–protein complexes upon the addition of imidazole. 
Developed by Lee et al., 2013. B – Scheme of experimental in-vivo Csy4-based RNA affinity 
purification developed in this work. Cells expressing Csy4 hairpin-tagged transcript are UV 
crosslinked. Biotinylated Csy4 protein and avidin dynabeads are first incubated with cell 
extract. After washing, the RNA–protein complexes are eluted by cleaving off the Csy4 
hairpin tag and releasing RNA–protein complexes on the addition of imidazole. C – Scheme 
of second experimental in-vivo Csy4-based RNA affinity purification approach developed in 
this work. Cells expressing STREP-tagged Csy4 protein and hairpin-tagged transcript are UV 
crosslinked. Strep-Tactin dynabeads are incubated with cell extract. After washing RNA 
bound proteins are released by RNase treatment. 
 
4.1.1. RNA pull-down with in-vitro purified Csy4 protein 
 In our first attempt we decided to express a transcript of interest fused with Csy4 
target hairpin at its 5’ end in HEK293 cells and use a recombinant catalytically inactive 
version of Csy4 protein to isolate the Csy4-hairpin-RNA from cellular lysates. Our goal was 
A           B               C 
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to be able to isolate endogenous transcripts that could be tagged with the stem loop sequence 
through genetic engineering. For the proof of concept experiments, however, we have relied 
on overexpressing the target transcript in cells. This way we could address the usefulness of 
the method more quickly and easily. The transcript we have chosen for this purpose was 
lncRNA called Hepatocellular Carcinoma Up-Regulated Long Non-Coding RNA (HULC). 
HULC is around 500 nt long RNA with known protein interactors (Hammerle et al., 2013). 
HULC protein interactors are normally expressed in HEK293 cells, which should allow to 
validate efficiency of pull-down of target transcript associated proteins. It has also been 
shown that overexpression of this lncRNA in human cells does not negatively influence cell 
viability (Yan et al., 2017).  
4.1.1.1. Enrichment for target transcript with in-vitro purified Csy4 
First, we confirmed overexpression of tagged HULC transcript in transfected HEK293 
cells with qRT-PCR (Fig. 2A). Next, we incubated biotinylated Csy4 mutant (provided by 
Meister laboratory, University of Regensburg) with cellular lysates from UV cross-linked 
cells expressing HULC transcript tagged with Csy4 target stem loop. To assay if Csy4 is 
capable of binding to its target RNA in cellular lysates we compared the recovery of target 
transcript after incubation with or without Csy4 followed by enrichment by avidin beads. 
Beads from positive and negative control samples were treated with proteinase K, followed by 
TRIzol extraction and qRT-PCR detection of the recovered target transcript. We successfully 
confirmed the recovery of HULC RNA and determined its 200 fold enrichment in the positive 
control when compared to the negative (Fig. 2B). Next, we sought to determine if the 
reactivation of Csy4 catalytic activity with imidazole to release the target transcript from the 
beads is possible. To this end we have performed two rounds of elution. First, Csy4-RNP 
complexes captured on beads were incubated with buffer containing imidazole. The second 
round of elution on the same beads was performed in the presence of proteinase K. Both 
eluates were analyzed with qRT-PCR. The analysis has shown that around 70% of input 
HULC was successfully eluted with imidazole treatment (Fig. 2C). The elution of HULC with 
imidazole was satisfactory. We decided to use it in further experiments as it has been shown 






































































































4.1.1.2. Specificity of RNA pull-down with in-vitro purified Csy4 
Next, we sought to assay the specificity of the pull-down approach. We have 
incubated Csy4 with cellular lysates, including cells not expressing the target transcript as a 
negative control. RNP complexes were enriched for and released from beads by activating 
Csy4 catalytic activity with imidazole. We have split eluates in two and prepared one half for 
analysis of pulled-down RNA and one for analysis of pulled-down proteins. We assayed 
recovered levels of HULC target transcript relative to GAPDH mRNA with qRT-PCR. We 
chose GAPDH mRNA for this analysis, since it was used before to assay specificity of a 
similar RNA pull-down methodology (Yoon et al., 2012; Yoon and gorospe 2016). Although 
HULC was clearly enriched when compared to levels of GAPDH, the mRNA was still clearly 
detectable with qRT-PCR. Levels of HULC transcript relative to levels of GAPDH mRNA in 
pull-down samples were on average around 8 times higher than its levels in input (Fig. 2D). 
The observed presence of target unrelated transcript may signify a problem with specificity in 













Figure 2. Efficiency and specificity of RNA pull-down with in-vitro purified Csy4 mutant 
protein. A – Levels of HULC in cells transfected with a plasmid expressing HULC tagged 
with Csy4 target stem loop, relative to HULC levels in cells transfected with plasmid 

































bars representing standard deviation is shown. B – Fold enrichment of tagged target transcript 
HULC pulled-down with Csy4 from transfected HEK293 cells, calculated over negative 
control with streptavidin beads without Csy4 protein, measured with qRT-PCR. Average of 
two biological replicates with error bars representing standard deviation is shown. C – 
Fractions of HULC target transcript successfully released from the beads with imidazole 
treatment and subsequent proteinase K elution, measured with qRT-PCR (100% = sum of the 
HULC transcript released with imidazole and with proteinase K treatment). Averages of two 
biological replicates with error bars representing standard deviation are shown. D – HULC 
transcript levels in input and Csy4 pull-down sample, normalized to levels of GAPDH, 
signifying the increase of HULC to GAPDH ratios after pull-down, measured with qRT-PCR. 
Averages of two biological replicates with error bars representing standard deviation are 
shown. E – Silver Stained SDS-Page gel picture showing proteins recovered in Csy4 pull-
down experiment. Proteins recovered in negative control where pull-down was performed on 
lysates from cells not expressing the tagged HULC target transcript and proteins recovered 
from cells expressing tagged HULC are shown. A representative example out of three 
biological replicates performed. 
 
To assay the possibility of detecting HULC-interacting proteins, we decided to check 
the protein composition of the eluate. Eluates from lysates that contained or lacked 
overexpressed HULC were separated by SDS-PAGE and visualized with silver staining. The 
experiment showed presence of wide range of proteins with different molecular sizes in pull-
down samples. This, pattern was similar to the negative control sample (Fig. 2E). The fact that 
imidazole driven elution from beads works through cleaving off Csy4-bound transcripts 
suggests that the high experimental background may be caused by unspecific Csy4 binding to 
non-target RNA. We have decided to redesign our pull-down approach to try to increase its 
specificity. 
4.1.2. RNA pull-down with Csy4 protein expressed in human cells 
We have attempted to pull-down Csy4 target transcript from cells expressing both the 
tagged transcript of interest and tagged Csy4 mutant protein to allow the binding to take place 
within the cells. We have developed constructs encoding human codon optimized Csy4 
mutant protein fused on its N-terminal end to FLAG/HA- or STREP/HA-tags. Using HEK293 
Flp-in cells we tried to develop cell lines stably expressing tagged Csy4 protein under 
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inducible promoter in which we could tag endogenous transcripts of interest with Csy4 target 
stem loops using genetic engineering or express tagged transcripts transiently from plasmids. 
Our attempts however, failed as no cells survived the antibiotic selection. 
We next decided to express Csy4 in HEK 293 cells transiently from plasmids for proof 
of concept experiments. For this purpose, we developed constructs encoding human codon 
optimized Csy4 mutant protein with N-terminal FLAG/HA- or STREP/HA-tags as well as 
different number of Csy4 target stem loops in its 3’ UTR (Fig. 3A). Although correct 
sequence of all used constructs was confirmed with sequencing for lack of mutations or 
sequence rearrangements, before they were used, the expression of FLAG/HA-tagged Csy4 
was only detected on low levels according to Western analysis (Supplementary Fig. 1A). 
Expression of STREP/HA-tagged version of the protein, however, was successfully detected 
with Western blot with observed molecular weight similar to the predicted one 
(Supplementary Fig. 1B). 
We used UV cross-linked, STREP/HA and target hairpin tagged Csy4 expressing 
HEK293 cells for the pull-down experiment. We have used three variants of the construct 
containing 1, 2 and 4 repeats of Csy4 target sequence in the 3’ end of the transcript (Fig. 3A). 
After enrichment for Csy4 with the beads half of them was proteinase K treated to recover 
isolated transcripts. The second half was treated with RNase and boiled in SDS to recover 
pulled-down proteins for analysis. The fact that Csy4 protein contacts with its target RNA 
may be stabilized by cross-linking in this approach demands a different elution method than 
activation of Csy4 enzymatic activity (Fig. 1C). We have tested the successful isolation of 
Csy4 from the lysates by Western analysis to make sure that potential low efficiency of the 
pull-down is not due to inefficient Csy4 capture. Lysates before incubation with Strep-Tactin 
beads and protein elutes were subjected to Western analysis. We have observed relatively 
efficient capture of the protein by the beads (Fig. 3B). An estimation of Csy4 protein pull-
down efficiency based on the Western blot image analysis with ImageJ software showed that 
we were able to pull-down around 15-20% of the protein from lysates (Fig. 3C). Next, we 
have used the transcript eluates to determine the target transcript pull-down efficiency and 
specificity with qRT-PCR. We have observed that in contrast to the previous approach after 
enrichment for the target transcript signal from target unrelated RNA GAPDH was detected 
on very low levels, whereas Csy4 mRNA signal was clearly enriched (Fig. 3D). The fraction 
of input Csy4 mRNA recovered however, was on levels of a fraction of percent, reaching 
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around 0.024%, 0.014% and 0.01% for transcripts tagged with 1, 2 and 4 repeats of Csy4 
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A – A scheme representing Csy4 FLAG/HA or STREP/HA tagged expression cassettes 
containing different number of repeats of Csy4 target stem loops (SL) in 3’ UTR in plasmids 
used for transient expression of the protein in HEK293 cells. B – A representative Western 
blot image with HA antibodies showing levels of Csy4 protein in input samples and in bead 
eluates from pull-down experiment performed on cells expressing Csy4 mRNA tagged with 1, 
2 and 4 Csy4 target stem loops. 1% of total input volume and 10% of total eluate volume per 
sample was loaded on gel. C – Amounts of Csy4 protein successfully eluted from beads in 
pull-down performed on cells expressing Csy4 mRNA tagged with 1, 2 and 4 repeats of Csy4 
target stem loop. The amounts of protein are presented as percentage of protein levels 
detected in input samples, quantified from image shown in figure A using ImageJ software 
quantification tool. D – Csy4 mRNA levels in input and Csy4 pull-down samples from cells 
expressing Csy4 mRNA tagged with different number of Csy4 target stem loops, normalized 
to levels of GAPDH, signifying the increase of Csy4 mRNA to GAPDH ratios after pull-
down, measured with qRT-PCR. Results from one biological replicate are shown with error 
bars representing standard deviation between technical replicates.  E – Amounts of Csy4 
target transcript successfully pulled down from cells expressing Csy4 mRNA containing 1, 2 
and 4 repeats of Csy4 target stem loop, measured with qRT-PCR, values represent amounts of 
pulled-down Csy4 mRNA as percentages of Csy4 mRNA in input samples. Averages of two 
biological replicates with error bars representing standard deviation are shown. 
 
4.2. LncRNAs expressed in DNA damage response 
 In order to identify differentially expressed lncRNAs in DDR, we have performed 
strand-specific RNA sequencing experiments on cells exposed to genotoxic stress. Human 
breast adenocarcinoma MCF-7 cells were treated with 10 Gy of ionizing radiation (IR) to 
induce DSBs, and RNA from cells 4, 8, 16 and 24h after exposure was sequenced. To gain a 
comprehensive picture of expression of lncRNAs, we have performed separate sequencing of 
polyadenylated, non-polyadenylated and nascent fractions of transcripts. 
4.2.1. Polyadenylated lncRNAs expressed in DNA damage response 
Investigation of differentially expressed polyA+ RNAs by sequencing using the 








Figure 4. Summary of polyA+ RNA sequencing experiment results. A – Four ellipse Venn 
diagram showing numbers of genes identified as differentially expressed in cells in different 
C          D 
E           F 
A                      B 
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time points after IR treatment. B - Four ellipse Venn diagram showing numbers of lncRNA 
genes identified as differentially expressed in cells in different time points after IR treatment. 
From C to F – Scatter plots showing results of the sequencing experiment. Log2 transformed 
FPKM expression values of genes in control cells and cells after exposure to IR of two 
averaged biological replicates are shown. Transcriptomes were mapped to Gencode.v19 
genome annotation and analyzed with DESeq2 and SeqMonk software. Genes with no 
significant expression change are marked in grey, differentially expressed genes are marked 
with blue for mRNAs and red for lncRNAs. C – cells 4h after IR treatment. D – cells 8h after 
IR treatment. E – cells 16h after IR treatment. F – cells 24h after IR treatment. 
 
in cells 4, 8, 16 and 24h after induction of DNA damage (Fig. 4A). Among those transcripts 
were mRNAs known to be typically upregulated in presence of DSB, including CDKN1A, 
MDM2 and BTG2, as well as known lncRNAs (Fig. 4C – F). In total, 24 different transcripts 
with no protein coding potential were shown to be differentially expressed, in at least one 
time point of IR treatment (Fig. 4B). Among them all but three had no known molecular 
functions in human cells at the time when this work was performed. The three differentially 
expressed transcript that were previously functionally characterized were MALAT1, NEAT1 
and LINC00086. To gain a more comprehensive picture of lncRNAs differentially expressed 
in DDR, we have repeated the sequencing analysis with a MCF-7 specific lncRNA annotation 
generated by GRO-seq (Sun et al., 2015). We were able to detect additional 5 lncRNAs 
differentially expressed in different time points of DDR that were not present in Gencode.v19 
genome annotation (Supplementary Table 1). None of those transcripts had their molecular 
functions known at the time of this work being performed. 
4.2.2. Non-polyadenylated lncRNAs expressed in DNA damage response 
 Before we analyzed the results of sequencing of transcripts depleted of polyadenylated 
and ribosomal RNAs, we sought to confirm that the depletion was successful. We have 
compared read coverage observed in depleted and in polyA+ samples. We have observed that 
relative amount of reads mapping to exons is strongly decreased in depleted samples, while 
relative mapping to genes is similar with polyA+ samples (Supplementary Fig. 2). This 
observation represents increased mapping of reads to unspliced pre-mRNAs, which lack a 






Figure 5. Scatter plots showing results of polyA-, ribo zero RNA sequencing experiments. 
Log2 transformed FPKM expression values of genes in control cells and cells after exposure 
to IR of two averaged biological replicates are shown. Transcriptomes were mapped to 
Gencode.v19 genome annotation and analyzed with Deseq2 and SeqMonk software. 
Differentially expressed genes that were not detected in polyA+ RNA sequencing are marked 
with blue. A – cells 4h after IR treatment. B – cells 8h after IR treatment. C – cells 16h after 
IR treatment. D – cells 24h after IR treatment. 
 
Sequencing of RNAs depleted of polyadenylated and ribosomal RNAs showed 
upregulation of many of the same transcripts as sequencing of polyadenylated RNAs. This is 
in line with the fact that most RNAs are upregulated on transcriptional level in DDR and they 
can be captured before polyadenylation takes place. Analysis of expression of transcripts not 
detected in sequencing of polyadenylated RNAs revealed additional 24 differentially 
A             B 
C             D 
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expressed transcripts. 0, 13, 2 and 13 such transcripts were detected in 4h, 8h, 16h and 24h 
after treatment with IR, respectively (Fig. 5). All of those additionally identified transcripts 
were lncRNAs, with no known molecular functions at the time of this work being performed.  
4.2.3. Detection of nascent RNAs in DNA damage response 
 To gain a more complete picture of gene expression dynamics in DDR we have 
performed additional RNA sequencing experiments utilizing metabolic 4-thiouridine (4sU) 
labeling. In this approach, we have sequenced the nascent transcriptome using incorporated 4-
sU with 5 min labeling performed before RNA extraction. Experiments were performed on 
control cells and cells 4, 8, 16 and 24h after IR treatment. Data analysis of the sequencing 
results was performed by Vedran Franke from the laboratory of Altuna Akalin, using an 
improved version of the antisense transcript detection algorithm introduced in Wyler et al., 
2017. Using this approach, we have identified various novel putative transcription units, 
which were not present in available gene annotations and were detected specifically in cells 
after IR treatment. Among them were transcriptional units, that are neither antisense to known 
genes nor appear to be associated with their promoters (Fig. 6). Those putative transcripts 
most likely represent novel lincRNAs. 
Nascent RNA sequencing provides information on the amount of transcription, not on 
the levels of mature RNAs, thus it can capture transcripts with little influence of their turn-
over rates. To verify the putative novel lncRNAs, we have checked if accumulation of reads 
mapping to their genomic regions can be also observed in polyA+ and polyA- sequencing 
experiments. Interestingly, we have found that one of investigated genomic region displayed 
strong increase in accumulation of mapped reads in nascent, polyA+ and polyA- sequencing 
experiments (Fig. 7A) and the second one displayed an increase only in nascent and polyA- 
experiments (Fig. 7B). This observation suggests that the first transcript is a polyadenylated 
RNA and that the second one is a non-polyadenylated RNA. We verified the expression of the 
putative polyadenylated transcript in DDR with qRT-PCR, using cDNA synthesized with 
oligo(dT) primer. The experiment confirmed induction of the putative lncRNA (Fig. 7C). The 
amplicon obtained in qRT-PCR was subjected to Sanger sequencing and its sequence matched 









Figure 6. Putative novel lincRNAs detected with nascent RNA sequencing. Coverage profiles 
of reads (values corrected for number of mapped reads) from two averaged biological 
replicates mapping to two genomic regions, which were not annotated in available genome 
annotations are shown. A – region on chromosome 17 (only reads mapping to forward DNA 
strand are visualized). B – region on chromosome 10 (only reads mapping to reverse DNA 






































































































































Figure 7. Validation of detection of putative novel lincRNAs. A and B – Coverage profiles of 
reads (values corrected for number of mapped reads) from two averaged biological replicates 
of nascent, polyA+ and poyA- RNA sequencing experiments mapping to two genomic 
regions, which were not annotated in available genome annotations are shown. A – region on 
chromosome 17 (only reads mapping to forward DNA strand are visualized). B – region on 

























































































































































































































of putative novel lncRNA originating from chromosome 17 in MCF-7 cells 4, 8, 16 and 24h 
after exposure to IR, relative to expression in untreated cells, normalized to GAPDH. 
Averages of two biological replicates with error bars representing standard deviation are 
shown. 
 
4.2.4. Circular RNAs expressed in DNA damage response 
 Sequencing results of samples depleted for rRNAs and polyA+ RNAs were also used 
to determine differential expression of circRNAs. This part of data analysis was performed as 
a part of collaboration by Peter Glazar from the Nicolaus Rajewsky laboratory. We were able 
to reproducibly detect 910, 2502, 3124, 1555, 2390 circRNAs in control cells and cells 4h, 8h, 
16h and 24h after exposure to IR respectively. To select from detected circRNAs potentially 
relevant for DDR, we focused on those with log2FC >2 or <2. The analysis revealed hundreds 
of circRNAs with increased expression values upon DDR. This increase in expression 
prevalently comes from detection of circRNAs in IR, which were not detected in control cells 
(Fig. 8A). We did not observe any circRNAs with decreased expression values in response to 
DNA damage. This observation does not seem to be an artifact of sequencing depth, as we did 
not obtain more mapped reads in IR treated samples than in controls (Supplementary Fig. 3). 
The upregulated circRNAs originated almost exclusively from protein coding host genes. The 
total number of circRNAs detected to be upregulated after IR treatment in at least one time 
point was 1311. They originated from 939 different genes, with some genes being hosts to 
multiple circRNAs. Gene ontology analysis of those host genes revealed that protein products 
of 675 of them are subjects to phosphorylation, a posttranslational modification that is a 
hallmark of DDR. Functional analysis of genes hosting circRNAs upregulated in response to 
IR showed that the most prevalent categories among them are Ubl conjugation pathway, 
protein transport and DNA damage (Fig. 8B). Some functionally characterized circRNAs are 
known to regulate expression of their protein-coding siblings, thus it is tempting to speculate 
that detected circRNAs are involved in regulation of the same processes as their protein 
coding counterparts. To see if any upregulated circRNAs have a regulatory potential towards 
linear products of their host genes, we looked for mRNA-circRNA pairs that both displayed 
changed expression in DDR according to polyA+ and polyA- ribo zero sequencing results. All 
quantified circRNAs originated from host genes that also produced detectable levels of linear 
 
-Log10 (adj P value)  




Figure 8. A – Number of circRNAs detected to be upregulated in sequencing of RNA 
depleted of polyadenylated and ribosomal transcripts in different time points after IR 
treatment in two biological replicates in MCF-7 cells. Blue – circRNAs detected after IR 
treatment, not expressed in untreated control cells. Red – upregulated circRNAs that were also 
expressed in control cells. B – GO enrichment analysis of genes being hosts to circRNAs 
upregulated in DDR. Top six ―biological function‖ categories shown are ranked by 
Benjamini-Hochberg adjusted P-value (Benjamini and Hochberg 1995). 
 
Table 9. Summary of information on mRNA-circRNA pairs originating from the same host 
gene that were differentially expressed in DDR. Average expression changes of two 
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circular transcript 














Gene involved in 
 
 
PIF1 4h -3.90 chr15:65115976-65116553 detected only in DDR DNA damage response 
MCM6 8h -1.40 chr2:136620176-136622733 detected only in DDR DNA replication 
DEPDC1B 8h -1.37 chr5:59934576-59943360 3.78 Wnt signaling pathway 
MCM10 8h -1.27 chr10:13214375-13228280 detected only in DDR DNA damage response 
GLS2 8h 2.28 chr12:56871443-56872046 detected only in DDR Glutamine metabolism 
UNG 8h -1.44 chr12:109539706-109541416 detected only in DDR DNA damage response 
DLGAP5 8h -1.78 chr14:55647930-55650471 detected only in DDR Cell cycle regulation 
XG 8h 2.26 chrX:2700106-2700169 detected only in DDR Plasma membrane 
PIK3R3 16h 1.19 chr1:46521466-46543285 detected only in DDR 
Regulation of protein-
tyrosine kinases activity 
KIF14 16h -2.09 chr1:200550328-200561368 detected only in DDR Cytokinesis 
MCM6 16h -1.90 chr2:136620176-136622733 detected only in DDR DNA replication 
KLHL24 16h 1.99 chr3:183361267-183369064 detected only in DDR Protein ubiquitination 
VPS13C 16h 1.34 chr15:62299506-62306191 detected only in DDR 
Intracellular trafficking 
and secretion 
POLE2 24h -2.13 chr14:50131343-50141145 2.17 DNA replication 
BRIP1 24h -1.84 chr17:59853761-59857762 2.00 DNA damage response 
WDHD1 24h -1.67 chr14:55448257-55467710 detected only in DDR DNA replication 
































































RNAs. However, we were able to find only a handful of cases in which expression of both 
mRNA and circRNA were changed at the same time point after exposure to IR (Table 9). 
Most of genes hosting those pairs had a DDR related function. It is possible that those 
circRNAs regulate their protein coding siblings in cis in response to genotoxic stress. 
4.2.5. Validation of expression changes of selected lncRNAs upregulated in DNA damage 
response 
 For further study we have selected four lncRNAs displaying highest upregulation in 
response to IR according to our RNA sequencing experiments, that were not functionally 
characterized before (Table 10). Two lincRNAs, LINC00475 and LINC01021, and two 
antisense lncRNAs, TCERG1L-AS1 and UNC5B-AS1. TCERG1L-AS1 sequence is 
contained within the last intron of Transcription Elongation Regulator 1 Like (TCERG1L) 
protein coding gene. Expression of the mRNA from this gene was not detected in our 
sequencing experiments. UNC5B-AS1 sequence is contained within the first intron of Unc-5 
Netrin Receptor B (UNC5B) protein coding gene, which is expressed in MCF-7 cells 
according to our sequencing experiments. UNC5B encodes a netrin receptor localized in 
plasma membrane. Netrin proteins are regulators of nervous system development, involved in 
the process of axon guidance (Sun et al., 2011). UNC5B is involved in netrin signaling, but it 
has an additional function in regulation of apoptosis and has been shown to promote TP53-
dependent apoptosis (Tanikawa et al., 2003). We have validated expression changes of 
selected lncRNAs in DDR with RT-qPCR using primers targeting parts of sequence with high 
coverage in RNA sequencing experiment (Fig. 9). To assay the potential role of selected 
lncRNAs in DDR we decided to attempt to knock them down with siRNAs. To be able to 
design efficient siRNAs, we first attempted to determine specific sequences of transcripts of 
interest in MCF-7 cells. Transcripts of interest were discovered and annotated in different cell 
lines and given relatively low pressure towards sequence conservation of lncRNAs, their 
sequences may not be exactly the same in MCF-7 cell as they are in reference assemblies and 
annotations. Moreover, some of the selected RNAs have multiple isoforms, being subjected to 
alternative splicing and polyadenylation. For example, LINC00475 has over 20 annotated 
alternative polyadenylation sites. Therefore, knowing at least part of a precise sequence of 
target transcripts may be important for efficient silencing under our experimental conditions. 
To determine suitable sequences to target, we performed a 3’ RACE on selected transcripts. 
For this experiment, cDNA derived from MCF7 cells 16h after induction of DNA damage 
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was used. We were able to determine around 400nt long 3’ sequence for each of the 
transcripts and clarify which isoforms were expressed (Table 10).  
 
Table 10. Information on lncRNAs differentially expressed in DDR selected for further study. 





















sites detected in 
MCF-7 
RP11-790G19.2 UNC5B-AS1 4h, 8h, 16h Antisense to UNC5B 5.25 not known 2 1 
LINC00475 lnc-CENPP 4h, 8h, 16h, 24h Intergenic 3.30 not known over 20 1 
RP11-462G8.3 TCERG1L-AS1 16h, 24h Antisense to TCERG1L 3.14 not known 1 1 




Figure 9. Expression of selected lncRNAs in MCF-7 cells 4, 8, 16 and 24h after exposure to 
IR, relative to expression in untreated cells, normalized to GAPDH. Averages of two 
biological replicates with error bars representing standard deviation are shown A – 
LINC00475. B – LINC01021. C – TCERG1L-AS1. D – UNC5B-AS1. 
 
4.2.6. Assessment of functions of selected lncRNAs in DNA damage response 
Two different siRNAs were designed to target each of selected lncRNAs within their 





























































































on cells 16h after IR treatment using RT-qPCR. Among all tested siRNAs, at least one for 
each target transcript allowed successful knock-down of around 50%, except for siRNAs 
targeting LINC01021, for which we were able to lower its target expression by only around 
13% (Fig. 10A). The knock-down efficiency of around 50% may not be sufficient to disrupt 
functions of the target transcript. We still decided to test the effects the lncRNAs may have on 
the cells’ ability to cope with DDR. For this purpose, we performed colony formation assays 
upon RNAi treatment, an experiment commonly used to measure rates of cells survival after 
induction of genotoxic stress. If lncRNAs of interest have a regulatory role in DDR, depleting 
them should affect the cells’ ability to cope with IR. We did not see any significant difference 
in the ability to form colonies between transfected and control cells after IR treatment (Fig. 
10B). This observation may reflect a lack of relevant functions of the tested lncRNAs, or an 
insufficient knock-down achieved with siRNAs, that did not disrupt their function, or that the 
transcription of the lncRNA is important and not the transcript itself. 
 
        
Figure 10. Knock-down efficiency of cells transfected with siRNAs targeting transcripts of 
interest and colony formation assay on transfected cells after transfection. A –expression 
values of lncRNAs of interest 48h after transfection with siRNAs and 16h after IR treatment 
relative to expression in mock treated cells 16h after IR treatment, normalized to expression 
of GAPDH. Averages of two biological replicates with error bars representing standard 
deviation are shown. B – average numbers of colonies formed by siRNA and mock 
transfected cells without and with IR treatment from two biological replicates, with error bars 
















































































































4.3. Regulation of human transcriptome by DDX3 
 A common feature of lncRNAs is that they are both regulated by proteins and often 
carry out their function in concert with RNA binding proteins (RBPs). Regulatory roles of 
RBPs in DDR are increasingly appreciated. The RNA helicase DDX3 has been reported to be 
one of the most highly enriched protein in the polyadenylated RNA-associated proteome in 
response to IR, which suggests that it may be another RNA binding protein involved in 
regulation of cellular responses to genotoxic stress (Milek et al., 2017). The protein is mostly 
studied in regard to its control of protein coding transcripts. It has been reported to control 
translation initiation on mRNAs with structured 5’ UTRs (Lai et al., 2008; Oh et al., 2016; 
Soto-Rifo et al., 2012). DDX3X is an essential gene in eukaryotes (Sharma and Jankowsky 
2014) and mutations are linked to diseases, including cancer (Epling et al., 2015; Jones et al., 
2012; Kool et al., 2014; Oh et al., 2016; Pugh et al., 2012; Robinson et al., 2012; Valentin-
Vega et al., 2016). The protein has also been reported to interact directly with lncRNAs, 
although to much lower extents than with mRNAs (Oh et al., 2016) and to be a part of larger 
lncRNA interacting protein complexes (Ribeiro et al., 2018). The functions that it plays 
through its association with lncRNAs are unknown and did not receive much attention. We 
have decided to study in more detail the nature of DDX3 interactions with RNAs and the 
significance they have for cells biology. 
4.3.1. DDX3 interacts primarily with protein coding transcripts 
 We have performed a PAR-CLIP experiment on cells overexpressing FLAG-tagged 
DDX3X protein in HEK293 Flip-in cells (Fig. 11A). The experiment was performed by 
Emanuel Wyler in the host laboratory and data analysis was performed by Lorenzo Calviello 
from University of California, San Francisco (UCSF). Before this work, iCLIP experiments 
on DDX3X protein were published, reporting the RNA binding sites of the protein (Oh et al., 
2016). The PAR-CLIP approach, however, allows utilization of T to C transitions in analysis 
of sequencing results, which are introduced specifically to uridines that were crosslinked to 
the bound protein. Those diagnostic transitions should allow increased specificity in analysis 
of DDX3X interacting sites on RNA. For our experiment, HEK293 Flp-In cells expressing 
inducible FLAG-tagged DDX3X protein were treated with 4-thiouridine (4sU) and RNA-
protein complexes were cross-linked using UV-A at 365 nm (Hafner et al., 2010). DDX3X 
cross-linked RNA fragments we determined using high-throughput sequencing and originated 
primarily from coding transcripts (Fig. 11B). This is in line with previously published data, 
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which showed that a major regulatory role of DDX3 is related to mRNA and translation 
regulation (Oh et la., 2016; Shih et al., 2008). In order to better understand regulatory roles 
that DDX3 plays through RNA interactions, we decided to further focus our work on the 
protein binding to mRNAs. 
 
 
        
 
Figure 11. DDX3 binds prevalently to mRNAs (Figure generated by Lorenzo Calviello). A – 
A representation of the PAR-CLIP experiment workflow allowing for determination of 
general and high confidence protein binding sites in the transcriptome during data analysis. B 
– Number of DDX3 binding sites among different classes of non-rRNA transcripts, 
determined with two biological replicates of PAR-CLIP (analysis performed by Emanuel 
Wyler and Lorenzo Calviello). 
 
4.3.2. A subset of human transcriptome is affected by DDX3 depletion 
To be able to identify transcripts that are regulated by DDX3, we performed ribosome 
profiling and mRNA sequencing experiments. We have attempted to develop HEK293 cell 
lines expressing endogenous DDX3 protein tagged with an auxin-inducible degron (AID) on 
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the C-terminus using the CRISPR/Cas9 system. AID allows for a rapid depletion of a protein 
in eukaryotic cells upon addition of auxin, a plant hormone not present in eukaryotic cells and 
neutral to their physiology (Natsume et al., 2016). In presence of auxin, proteins bearing the 
AID tag become subject to ubiquitination and degradation, which is able to knock-out the 
protein within 24h (Natsume et al., 2016). We have reasoned that a complete depletion of 
DDX3 with an AID-based system would be beneficial to our analysis. Residual expression of 
a target in knock-down approaches may confer functions that are difficult to assay and may 
obscure the full picture of function of the protein of interest. We were successful in selecting 
for viable cells bearing an AID knock-in in the terminus of DDX3-coding sequence, however 
failed to induce the protein degradation with auxin (data not shown). We did not determine 
the precise reason for this failure at the time of performing this study and instead decided to 











Figure 12. Ribosome profiling approach performed on cells depleted of DDX3 protein (Figure 
generated by Lorenzo Calviello). A – A workflow of ribosome profiling experiment. B –
Image of Western blot analysis showing levels of DDX3X protein and Vinculin loading 
control in HEK293 control cells and cells 48h after transfection with either non-targeting 
control, or DDX3-targeting siPOOLs.  
 
We have used HEK293 cells transfected with siRNAs targeting DDX3 mRNA or 
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Lorenzo Calviello. We have ribosome profiling data to determine changes in translation and 
used the mRNA sequencing data to normalize for changes in transcript abundance in order to 
be able to calculate translation efficiency (TE) changes upon DDX3 depletion. We observed 
that most expressed transcripts do not display significant changes in their abundance nor in 
TE upon depletion of DDX3 (Table 11 and Fig. 12A). About 6% and 7% of expressed 
mRNAs were downregulated and upregulated, respectively. This observation is in line with 
previously published data, where changes of expression level of DDX3 did not strongly affect 
abundance of transcripts (Shih et al., 2008). We have also determined that only around 2% of 
all expressed mRNAs displayed changed TE (Table 11). Among those changes, decreased TE 
upon DDX3 knockdown was more prominent. Those results are in line with data published 
before, which reported that DDX3 does not affect translation globally, but appears to be 
necessary for controlling this process on a subgroup of mRNAs containing structured 5’ 
UTRs (Lai et al., 2008). At the same time, they are in contrast with a report stating that 
changes of DDX3 levels have dramatic effects on protein synthesis (Shih et al., 2008). We 
have also performed a gene ontology (GO) analysis of transcripts affected by DDX3 depletion 
(Fig. 13B). An example of a gene affected by DDX3 depletion is ODC1 (Fig. 13C), which is 
known to be subject to translational control and is implicated in protecting cells from DNA 
damage and in cancer. (Gerner and Meyskens 2004; Hogarty et al., 2008).  
 
Table 11. Summary of number of genes that change translation and mRNA expression levels 
after DDX3 knock-down. TE – translation efficiency (the ratio of ribosome protected 
footprints to RNA). Determined from two averaged biological replicates of ribosome profiling 
and mRNA sequencing. 
  Not significant RNA level down RNA level up TE down TE up 
Number of genes 10365 792 913 249 34 
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Figure 13. Depletion of DDX3 affects translation (Figure generated by Lorenzo Calviello). A 
– Representation of differential expression and changes in ribosome occupancy on mRNAs 
upon DDX3 knock-down determined with averaged data from two biological replicates of 
mRNA sequencing and ribosome profiling. RP – ribosome profiling. B – Gene ontology 
terms enriched in sets of genes transcripts of which change their level or TE upon DDX3 
depletion. C – Effects of DDX3 knock-down on translation and expression of ODC1 mRNAs. 
Averaged results from two biological replicates are shown. 
 
4.3.3. Depletion of DDX3 affects translation initiation  
The yeast ortholog Ded1 has been reported to translationally regulate its target 
mRNAs through interactions with their 5’ UTRs (Guenthler et al., 2018; Gupta et al., 2018). 
A similar regulation has been observed in case of individual mRNAs in human cells (Ku et 
al., 2018; Lai et al., 2008; Lai et al., 2010; Soto-Rifo et al., 2012). However, this regulation 
has not been investigated in human cells on a transcriptome-wide scale. We have focused our 
attention on 5’ UTRs in analysis of generated data to investigate DDX3-mediated regulation 
of this structure in whole transcriptome. We have observed that depletion of DDX3 with 
siRNAs led to increased detection of ribosome footprints in 5’ UTRs when compared to the 
coding sequences (Fig. 14A). This effect was most pronounced for the transcripts that had 
their TE reduced upon depletion of the protein (Fig. 14A and Fig. 14B). Accumulation of 
ribosomes in 5’ UTRs upon depletion of DDX3 may reflect defects in initiating translation by 
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agreement with previously reported functions of DDX3 and its association with translation 
initiation factors (Lee et al., 2008; Soto-Rifo et al., 2012). To test the hypothesis that DDX3 
regulates translation initiation of mRNAs with structured 5’ UTRs, we analyzed properties of 
5’ UTRs of transcripts affected and unaffected by DDX3 depletion. We have not seen any 
strong differences in 5’ UTR lengths of transcripts differentially regulated by DDX3 (Fig. 
14C). However, GC content of analyzed regions was clearly increased in transcripts that 
displayed lower TE upon DDX3 depletion, especially when compared with genes that 
displayed lower TE (Fig. 14C). GC content of a transcript is in general a good predictor for 
the presence of secondary structure (Galtier and Lobry 1997; Dohm et al., 2008), including 
RNA G-quadruplexes (rG4) (Murat et al., 2018). We have analyzed the predicted secondary 
structures in 5’ UTRs of RNAs and indeed found that in case of transcripts with lower TE 
upon DDX3 depletion, the predicted folding free energy was lower than that of other 
transcripts (Fig. 14D). Those findings support the hypothesis that there is a general connection 
between DDX3 mediated translation regulation and structure of 5’ UTRs. They are also in 
line with recently reported DDX3 in-vitro interaction with rG4 structure from a 5’ UTR of a 
human transcript (Herdy et al., 2018).  
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Figure 14. Transcripts sensitive to DDX3 depletion have more structured 5’ UTRs (Figure 
generated by Lorenzo Calviello). A – Representation of the ratio of fold-change in ribosome 
occupancy in the 5’ UTR to the coding sequence in transcripts affected and unaffected by 
DDX3 depletion, averaged from two biological replicates. B – An example of a 
Hydroxymethylbilane Synthase (HMBS) gene displaying increase in ratio of ribosome 
occupancy in the 5’ UTR when compared to the coding sequence. Averaged result from two 
biological replicates are shown. C – Representation of number of mRNAs having different 
characteristics of their of 5’ UTRs (5’ UTR length – upper panel; 5’ UTR GC content – lower 
panel) for groups of transcripts affected and unaffected by DDX3 depletion, determined from 
two averaged biological replicates. D – A representation of predicted Gibbs free energy 
values along 5’ UTR sequences of transcripts affected and unaffected by DDX3 depletion. 
4.3.4. DDX3 specifically binds to 5’ UTRs 
To better understand DDX3 mediated regulation of mRNAs and their 5’ UTRs, we 
analyzed the aforementioned PAR-CLIP data in combination with results obtained with 
ribosome profiling and mRNA sequencing. We have used sequenced RNA fragments to 
determine general DDX3 binding sites and the advantage of presence of diagnostic T to C 
transitions in those reads to determine high confidence binding sites (Fig. 15A and B). By 
analyzing sequenced non-rRNA RNA fragments that were identified as DDX3 bound in PAR-
CLIP experiment, we have determined that the protein binds to most mRNAs expressed in 
HEK293 cells (Table 12). The majority of bound transcripts were not affected by DDX3 
depletion on level of transcript abundance nor TE. To gain more insight into the context of 
DDX3-binding to RNAs we decided to assay the averaged binding of the protein to specific 
regions of the transcript by averaging detected reads across all expressed transcripts in a 
metagene analysis. We also compared DDX3 binding to binding pattern of Eukaryotic 
Translation Initiation Factor 3 Subunit B (eIF3B), Fragile X Mental Retardation 1 (FMR1) 
and Mov10 RISC Complex RNA Helicase (MOV10) proteins, which were determined by 
PAR-CLIP experiments before this work and are available in the POSTAR2 database (Zhu et 
al., 2019). EIF3B is a part of the translation initiation complex (Aitken et al., 2016), FMR1 
associates with elongating ribosomes (Chen et al., 2014) and MOV10 binds to 3’ UTRs 
(Sievers et al., 2012; Gregersen et al., 2014). We have observed that the strongest DDX3 
binding happened in 5’ UTRs, with the highest peak near the start codon (Fig. 15A). The 
protein binding was also observed in the coding sequence and in 3’ UTRs, albeit at lower 
levels than the binding to the 5’ UTR. This binding pattern correlates best with binding of 
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eIF3B (Fig. 15A), which is a protein having core functions in translation initiation. The 
protein associates with 40S ribosome and facilitates the recruitment of factors creating pre-
initiation ribosome complex (Wagner et al., 2016). The metagene analysis of high confidence 
binding sites represented by T to C transitions in the PAR-CLIP approach determined an even 
clearer prevalence of DDX3 binding near the start codon (Fig. 15B). This binding pattern was 
observed also for genes that displayed reduced TE upon DDX3 knock-down, examples of 
which are PRKRA and ODC1 (Fig. 15C). In addition to high frequency of binding to 
mRNAs, we have determined DDX3 binding to 18S ribosomal RNA (Fig. 15D). The major 
interaction site was mapped to helix 16 of the 18S rRNA. This position of DDX3 may provide 
access to resolve mRNA secondary structures during inspection by the scanning ribosome. 
The observed cross-link site is opposite to the eIF4B binding site, a factor important for 
ribosome function (Walker et al., 2013; Sen et al., 2016). This is also in line with previously 
observed association of DDX3 with eIF3 (Lee et al., 2008). Taken together, those results are 
consistent with previously reported association of DDX3 with translation initiation machinery 
and its requirement for translation initiation of specific mRNAs (Soto-Rifo et al., 2012), 
which bears resemblances to translation regulation of the DDX3 ortholog Ded1 in yeast (Sen 
et al., 2015). 
 
Table 12. Summary of effects of DDX3 depletion on transcriptome. Numbers of transcripts 
effected on the level of abundance and TE, as well as numbers of transcripts directly bound by 
DDX3 in differently effected groups of transcripts are shown Determined from two averaged 
biological replicates of ribosome profiling and mRNA sequencing. 
 
All detected RNA level up RNA level down TE up TE down 
Detected genes 12054 617 792 34 249 
DDX3-bound (% of detected genes) 8869 (73.6%) 492 (79.7%) 496 (62.6%) 28 (82.4%) 211 (84.7%) 
DDX3-bound, high T to C transition 








































































































































Figure 15. DDX3 binds to 5’ UTRs of mRNAs, similarly to canonical translation initiation 
factor (Figure generated by Lorenzo Calviello). A – Metagene plot of DDX3, eIF3B (a 
canonical translation initiation factor), FMR1 (associates with elongating ribosomes) and 
MOV10 (a helicase binding to 3’ UTRs) PAR-CLIP data showing protein occupancy along 
the transcript body. B – Metagene plot of DDX3 PAR-CLIP data utilizing peaks of T to C 
transitions from two averaged biological replicates, showing protein occupancy along the 
transcript body. C – Examples of two genes (PRKRA and ODC1) whose transcripts were 
identified to be bound by DDX3 and displayed reduced TE upon the protein knock-down. In 
Panel PAR-CLIP grey color represents mapping of reads from the experiment and dark blue 
high frequency of T to C transitions. Averaged result from two biological replicates are 
shown. D – Representation of sites of high confidence DDX3 binding to ribosomal RNA, 
assayed by peaks of T to C transitions from two averaged biological replicates of PAR-CLIP 
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(upper panel) and compared to binding determined with iCLIP by Oh et al., 2016 (bottom 
panel). 
4.3.5. DDX3 binds preferentially to GC-rich mRNA regions 
 The DDX3 binding to 5’ UTRs of transcripts that display decreased TE observed in 
this study allowed us to investigate a connection between 5’ UTR structure and transcripts 
whose translation depends on DDX3. This connection has been observed before for certain 
examples of human mRNAs (Ku et al., 2018; Lai et al., 2008; Lai et al., 2010; Soto-Rifo et 
al., 2012) and for DDX3 ortholog from yeast Ded1 (Guenther et al., 2018; Gupta et al., 2018). 
We first checked if DDX3 displays preference for binding to structured 5’ UTRs. We have 
observed that PAR-CLIP peaks with high T to C transitions occur in GC-rich regions with 
high specificity (Fig. 16A). Next, we checked how T to C conversions, which represent 
DDX3 binding, change across bodies of mRNAs that are sensitive and insensitive to the 
protein knock-down. We have found that enriched DDX3 binding to 5’ UTRs is specific to 
transcripts that displayed decreased TE upon the protein knock-down (Fig. 16B). Those 
results suggest that there is a direct relationship between DDX3-depletion and the observed 
decrease in TE. They confirm the previous observations that DDX3 associates with protein 
complexes controlling translation initiation. The helicase however is required for translation 
initiation of only of subset of mRNAs. Our observations support the notion that those mRNAs 
require DDX3 activity to resolve RNA structures in their 5’ UTRs to permit translation 
initiation by the ribosome. 
 
         
Figure 16. DDX3 binding regulates translation of GC-rich transcripts (Figure generated by Lorenzo 
Calviello). A – Representation of GC content of regions of DDX3 binding determined by peaks of T 
to C transitions from averaged two biological replicates of PAR-CLIP experiments. B – A metagene 
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averaged biological replicates of PAR-CLIP experiments along transcript bodies of genes affected and 
unaffected by depletion of DDX3. 
 
4.3.6. DDX3 specifically binds 5’ ends of lncRNAs 
DDX3 prevalently associates with mRNAs, but its binding to lncRNAs has also been 
observed (Fig. 11B). This interaction has been reported before, but it has not been analyzed 
(Oh et al., 2016). We have decided to investigate the nature of DDX3 binding to lncRNAs 
using PAR-CLIP data. We have observed that protein binding along averaged lncRNA 
transcript body has a similar pattern as observed for mRNAs (compare Fig. 15B with Fig. 
17A), with most prevalent binding spotted near the 5’ end of transcripts. This binding 










Figure 17. DDX3 binds preferentially near 5’ ends of lncRNAs. A – Metagene plot of DDX3 
PAR-CLIP data averaged from two biological replicates, showing protein occupancy along 
the length of averaged lncRNA transcript body from two averaged biological replicates. B – 
Representative examples of three lncRNA genes whose transcripts were identified to be 
bound by DDX3. Coverage profiles of mapped PAR-CLIP reads containing T to C transitions 
from two averaged biological replicates are shown. Color of gene annotation represents the 






































































5.1. The need for novel RNA pull-down methodologies 
Numerous approaches to enrich for the RNA of interest along with its protein 
interactors have been developed prior to this work. The traditional in-vitro approaches, where 
RNA of interest is in-vitro transcribed, immobilized and then incubated with a cellular lysate 
are associated with high levels of binding by molecules which under physiological conditions 
do not interact with the transcript of interest (Treiber et al., 2017). This problem seriously 
hampers usefulness of those methods in identifying biologically relevant RNA-protein 
interactions. This issue was addressed in the approach utilizing Csy4 molecule for the in-vitro 
RNA pull-down, where conditional version of the enzyme allowed for specific elution of the 
transcript bound by it (Lee et al., 2013). This has lowered levels of background signal 
obtained in the approach but did not eliminate the problem.  
While work presented in this thesis was being performed RNA pull-down approaches 
relying on affinity purification with biotinylated oligonucleotides were being reported to be 
successful in identification of proteins associating with single transcript in combination with 
mass spectrometry (Chu et al., 2015; Warneford-Thomson et al., 2017). Due to their high 
efficiency they may be considered a golden standard for identification of proteins interacting 
with single RNA of interest. Their major disadvantage, however, is high cost of an array of 
biotinylated oligonucleotides that has to be purchased for each target RNA. This has been a 
limiting factor in popularization of the approach. 
A wide array of affinity purification methods utilizing an RNA sequence which can be 
fused to a transcript expressed in cells and is bound by a specific molecule has been 
developed in the past (Bachler et al., 1999; Hartmuth et al., 2002; Srisawat and Engelke 2001; 
Youngman and Green 2005; Yoon et al., 2012). The advantage of those approaches in 
comparison to in-vitro pull-downs is that they allow capture of RNA-protein interactions that 
form in living cells. This allows capturing the RNA-protein interactions that better reflect in-
vivo contacts of those molecules and limit experimental background. The optional use of 
cross-linking to induce covalent bonds between target transcript and associated with it 
proteins is another advantage that may further increase faithful capture of in-vivo interactions. 
Those methods were successful in purification and identification of molecules associated with 
target transcript in combination with highly sensitive methods like next-generation 
sequencing and Western analysis (Yoon et al., 2012; Yoon and Gorospe 2016). Their use for 
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de-novo identification of proteins associated with a transcript of interest has been limited and 
required overexpression of the targeted RNA (Li and Altman 2002; Dong et al., 2015). Those 
methods have not been often utilized owing to their technical challenges. In particular, low 
affinity or specificity of target RNA recognition have limited the widespread use of 
approaches based on aptamers, and bacteriophage coat protein binding sites. We have 
attempted to overcome those limitations by utilizing Csy4 protein for an in-vivo RNA pull-
down. The protein has been shown to have exceptionally high affinity towards its target 
(equilibrium dissociation constant, Kd = 50 pM), and sequence specificity (Sternberg et al., 
2012). This is a markedly higher affinity than that of molecules previously used for in-vivo 
RNA pull-down approaches based on bacteriophage MS2 coat protein and S1m streptavidin 
binding aptamer. MS2 interaction with its target stem loop has Kd = 20 nM (Stockley et la., 
1995) and S1m interaction with streptavidin has Kd = 29 nM (Leppek and Stoecklin 2013). 
We have reasoned that utilization of a protein with such a high binding affinity has a chance 
to outperform approaches based on molecules with comparably low affinities towards their 
targets. 
5.1.1. RNA pull-down with in-vitro purified Csy4 displays low target capture specificity 
 The utilization of Csy4 for pull-down approaches is possible thanks to development of 
a catalytically inactive version of this protein, which allows stable binding to the target stem 
loop without subsequent cleavage. The mutant version of Csy4 has its histidine residue 29 
mutated to alanine (H29A) resulting in a conditional enzyme inactive under normal 
conditions. The catalytic activity can be rescued in the presence of imidazole (Lee et al., 
2013). Our first approach utilizing recombinant, in-vitro purified Csy4 protein incubated with 
lysates from cells expressing HULC transcript tagged with Csy4 target hairpin succeeded in 
enriching for the transcript. It was, however associated with high experimental background 
levels reflected by apparent isolation of wide array of unrelated proteins (Fig. 2E) and of 
target unrelated transcript GAPDH (Fig. 2D). In this approach we have used conditional Csy4 
mutant protein, which allowed imidazole driven elution of bound transcripts (Fig. 2C). This 
mode of elution has been shown before to specifically release transcripts directly bound by 
the protein and reduce background signal of unrelated molecules (Lee et al., 2013). Thus, 
observed enrichment for target unrelated transcript GAPDH and wide array of proteins in both 
negative and positive controls most likely reflects indiscriminate interactions of Csy4 protein 
with cellular RNAs. Csy4 has been shown to interact with its targets with high specificity 
under favorable in-vitro conditions (Sternberg et al., 2012). Moreover, Csy4 target sequence 
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is not normally present in the human transcriptome and Csy4 protein was not observed to 
target sequences other than the target stem loop when both molecules were expressed in 
human cells (Borchardt et al., 2015). Therefore, we have hypothesized that the environment of 
cellular lysate had a negative influence on activity of the protein, which resulted in its 
unspecific interactions with RNAs and observed levels of isolated proteins in our samples. 
Low specificity of this approach rendered it not useful for intended purpose and prompted us 
to test the second one. 
5.1.2. RNA pull-down with Csy4 expressed in cells displays low target capture efficiency 
 In our second approach we expressed in cells the tagged Csy4 protein, mRNA of 
which was at the same time tagged with Csy4 target stem loops. In this system the interaction 
between the protein and its target was allowed to take place within cells and could be cross-
linked in-vivo. Csy4 has been successfully expressed in human cells in a previous study 
retaining its enzymatic activity (Borchardt et al., 2015). Thus, capturing mutant Csy4-target 
transcript interactions in human cells seemed plausible. In this approach unlike in the 
previously tested one we did not detect high levels of target unrelated GAPDH transcript (Fig. 
3D), even though the mode of elution used in this approach was not specific for Csy4 bound 
transcripts. This reinforced our view, that an issue of high experimental background levels 
observed in previously tested system reflected unspecific Csy4-RNA interactions under 
conditions of cellular lysate. However, the enrichment for the target mRNA was very modest 
in our second system (Fig. 3E). Our result is far from satisfactory when compared with 
affinity purification methods that we were hoping to outperform. Methods relying on use of 
MS2 coat protein and of S1m RNA binding aptamer achieve fraction of input target RNA 
recovered of ~1% and ~5% respectively (Leppek and Stoecklin 2013). Given the fact that 
Csy4 affinity towards its target is markedly higher than that of MS2 and S1m the results we 
achieved were unsatisfactory. Quantitative determination of in-vivo RNP composition 
requires isolation of significant amounts of RNAs from cellular lysates and it has been 
reliably achieved on endogenous transcripts only with methods utilizing biotinylated 
oligonucleotides, which were successful in recovering around 50% fraction of input target 
RNA (Simon et al., 2011). To be useful for intended purposes our system would have to at 
least perform better than S1m and MS2 based methods. 
The low efficiency of enrichment for Csy4 mRNA could not be explained by the 
failure to enrich for the Csy4 protein from the lysate, as this step of the experiment appeared 
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to work relatively well in our hands (Fig. 3B and Fig. 3C). The disproportion between 
amounts of isolated Csy4 protein and isolated Csy4 tagged mRNA we have observed in our 
experiments suggests that Csy4 does not interact with its target efficiently in cells. We have 
assumed that after transfection levels of Csy4 protein in human cells are higher than those of 
its host mRNA as is true for most mRNAs in human cells (Silva and Vogel 2016; Liu et al., 
2016), thus we did not expect low protein to transcripts ratios to be a limiting step in this 
approach. In a similar experimental pull-down design utilizing tagged MS2 coat protein both 
the protein and its target transcript are expressed under the same promoter as Csy4 in our 
approach and no problem with protein to transcript ratios was reported (Yoon et al., 2012). 
The low Csy4 protein to mRNA ratio in transfected cells is, however, a possible explanation 
of observed results. This could be caused by rapid Csy4 protein degradation in human cells. 
We did not, however observe any evidence for the protein degradation with Western analysis. 
Another possible reason for low Csy4 protein to mRNA ratio in transfected cells is inefficient 
protein translation. It seems possible that the presence of Csy4 target stem loop in 3’ UTR of 
Csy4 mRNA has a negative effect on efficiency of translation. However, this assumption is 
contradicted by previous study showing that levels of a reporter protein encoded by a mRNA 
containing Csy4 target stem loop in its 3’ UTR were not affected in presence of the Csy4 
mutant protein in human cells (Borchardt et al., 2015). 
Another possible explanation for low efficiency of the pull-down approach utilizing 
Csy4 protein and its mRNA tagged with Csy4 target stem loops is that folding of Csy4 target 
stem loop RNA sequences is inefficient. This could lead to lack of appropriate structures that 
can be bound by the protein. Inefficient folding has been shown to be a limiting step in case of 
pull-down with S1m RNA aptamer. That limitation could be circumvented by increasing the 
number of repeats of sequence forming S1m structure on the target transcript (Leppek and 
Stoecklin 2013). In our approach, however increasing the amount of Csy4 target stem loops 
on the Csy4 mRNA did not increase the pull-down efficiency (Fig. 3E). Thus, suggesting that 
inefficient RNA folding was not the limiting step in our approach. Another potential 
explanation for inefficient Csy4-RNA interaction in cells is that the protein may be actively 
removed from its target by RNA helicases. Testing this hypothesis, however, is difficult and 
we did not address it in our work. 
 Taken together we have determined that using recombinant in-vitro purified Csy4 
mutant protein for the pull-down with cellular lysates is not suitable for efficient enrichment 
of Csy4 stem loop tagged transcripts. This approach did not show promise for further 
83 
 
optimization and for use for identification of proteins associated with a transcript of interest. 
Our second approach with Csy4 and target transcript both expressed in cells did not meet our 
expectations either. We were, however, unable to clearly determine the reason for its low 
efficiency. It is possible that further optimization of the method may result in a system useful 
in identification of RNA-protein interaction with single transcript resolution. Our results, 
however, are not encouraging. 
5.2. Landscape of non-coding transcriptome in DNA damage response  
 We have determined the transcriptional landscape of MCF-7 cells in response to DNA 
damage induced by gamma-irradiation. Our goal was to identify novel lncRNAs involved in 
DDR. By separately sequencing polyadenylated, non-polyadenylated and nascent fractions of 
the transcriptome, we were able to analyze differential expression of diverse classes of 
transcripts independently of the properties of their 3’ ends or turnover rates. Our approach 
allowed us to determine differential expression not only of linear transcripts, but also of 
circRNAs, for which differential expression in DDR has not been reported previously. By 
performing sequencing experiments on cells in various time points after induction of DDR, 
we were able to dynamically capture transcript up- or downregulation in response to 
genotoxic stress. Our work provides an extended insight into the transcriptional landscape 
during the DDR. 
 In the polyA+ sequencing experiment, alongside mRNAs typically upregulated in 
DDR, we have initially detected 24 differentially expressed lncRNAs (Fig. 4). Of those non-
coding transcripts, 21 did not have a known molecular function at the time when this analysis 
was performed. A subsequent analysis with an MCF-7 specific genome annotation revealed 5 
additional differentially expressed transcripts, which were not annotated in Gencode.v19 
genome annotation. We sought to identify additional lncRNAs differentially expressed in 
DDR by sequencing non-polyadenylated fractions of transcripts. In this experiment, we have 
identified additional 24 differentially expressed lncRNAs (Fig. 5). 
Standard RNA sequencing experiments use whole-cell RNA extractions, thus limiting 
gene expression analysis to steady-state RNA abundance levels. We have complemented our 
efforts in investigating transcriptomes of cells exposed to DNA damage by performing 
nascent RNA sequencing. With this method we were able to enrich for unstable transcripts. 
This data provides a valuable insight into expression of short-lived transcripts expressed in 
DDR, which are difficult to capture with traditional sequencing approaches. Using nascent 
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RNA sequencing we were able to detect novel transcription units, which were not present in 
available genome annotations. Two novel transcription units that we presented in this work 
are intergenic and longer than 200 nt (Fig. 6). Interestingly, both transcripts appear not to be 
rapidly turned-over in cells as we could also detect their signatures with sequencing of steady 
state RNAs (Fig. 7A and B). Moreover, we were able to successfully quantify one of those 
transcripts using qRT-PCR from cDNA library derived from polyadenylated RNAs. Our 
results show that nascent RNA sequencing approach may be used for identification of novel 
transcriptional units with success. The dataset we have generated will also be useful in future 
studies of novel and short lived RNAs with potential functions in DDR. 
5.2.1. Evaluation of functions of LINC00475, LINC01021, TCERG1L-AS1 and UNC5B-
AS1 in regulation of DNA damage response required further study 
From the lncRNAs identified as differently expressed in DDR, we have selected those 
displaying highest expression changes and confirmed their upregulation with qRT-PCR (Fig. 
9). We have attempted to assay roles selected transcripts may play in cell survival after 
induction of IR. To this end we have knocked-down their expression using siRNAs and 
performed colony formation assay after knock-down of three lncRNAs that we were able to 
deplete. We did not, however, detect any significant influence on cell survival after the knock-
down (Fig. 10). This observation may reflect lack of regulatory roles played by selected 
lncRNAs in DDR. It may, however, also be caused by inefficient knock-down of those 
transcripts by siRNAs. We were able to knock-down three out of four selected lncRNAs and 
only to around 50% of their initial levels. This level of knock-down may be insufficient to 
disrupt function of targeted transcripts. Alternatively, it is possible that knocked-down 
lncRNA genes maintain their function through the act of transcription itself and resulting 
transcripts themselves are non-functional. Functionality of those lncRNAs should be assayed 
further with a different approach then siRNA knock-down, such as CRISPR-Cas9 mediated 
deletions. Potentially, a more efficient knock-down of lncRNAs may be achieved with RNase 
H activate antisense oligonucleotides (ASOs), which utilizes an endogenous RNAse H 
enzyme, which is prevalently localized in the nucleus. This method of knock-down has been 
shown to be more efficient then siRNAs for some lncRNA targets, especially when the 
transcript is localized to the nucleus (Lennox and Behlke 2016). This could be particularly 
important in the case of lncRNAs assayed in this study, as according to the NONCODE 
database (http://www.noncode.org/), only one of them (UNCB5B-AS1) prevalently localizes 
to  the cytoplasm. 
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5.2.2. Circular RNAs are likely involved in regulation of DNA damage response 
In addition to the aforementioned analysis of differential gene expression, we have 
performed an analysis of differential expression of circRNAs. The sequencing experiment of 
transcripts depleted of polyadenylated and ribosomal transcripts provides an enrichment of 
circRNAs, which is suitable for such an analysis (Linda and Salzman 2016). To our 
knowledge, this is the first report of differentially expressed circRNAs in DDR. We have 
detected high number of upregulated circRNAs in all time points of DDR. Interestingly, the 
majority of upregulated circRNAs were not detected in IR untreated control samples (Fig. 
8A). We detected a wealth of circRNAs that seem to be DDR-specific in MCF-7 cells. Those 
transcripts prevalently originated from protein coding genes. We have performed a GO 
analysis of genes harboring circRNAs upregulated in DDR and observed that they were 
involved in plethora of regulatory functions, including DDR-related processes (Fig. 8B). The 
expression of the respective host genes was mainly unchanged. We were able to find 17 
mRNA-circRNA pairs originating from the same gene, which both displayed differential 
expression in DDR (Table 1). Most of those genes had known functions related to DDR. 
Many functionally characterized circRNAs have a function in regulating expression of their 
mRNA siblings. Therefore, it is tempting to speculate that circRNAs from the above-
mentioned mRNA-circRNA pairs have regulatory roles in DDR by influencing the levels of 
the respective mRNAs. Elaborating these relationships might be interesting for future studies. 
In summary, we have provided a comprehensive picture of temporal transcriptome 
changes of human cells upon DDR, including the differential expression of circRNAs, which 
was not reported before this work. We did not succeed in identifying novel functional 
lncRNAs regulating DDR, but we have provided information potentially useful in future 
studies of those molecules. 
5.3. DDX3 regulates translation of a subset of its target mRNAs 
We have determined for the first-time transcriptome-wide effects of DDX3 depletion 
on translation efficiency in human cells. In combination with investigation of DDX3 binding 
sites and measuring mRNA abundance upon knock-down, this allowed us to provide a new 
important insight into DDX3 modes of action and to verify previously reported information 
on DDX3 function and. Although DDX3 is an essential gene and according to our data binds 
to most expressed mRNAs in human cells, we observed that its depletion affects translation 
efficiency of a relatively small subset of targets. This observation may reflect a bias in our 
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approach, which failed to detect changes in translation efficiency of additional DDX3 targets. 
This bias may come from the limitations of siRNA technology in completely depleting the 
protein of interest from cells, resulting in levels of protein, which still may be enough to 
maintain most of the protein functions in cells. The results we have produced argue that the 
main role of the protein is to promote translation of a subset of transcripts. The DDX3 gene is 
altered in many diseases. Our discoveries further the understanding of DDX3 functions, 
which may be useful for understanding human pathologies in which this protein is implicated. 
5.3.1. DDX3 binding to coding and non-coding transcripts displays a similar pattern 
 Using PAR-CLIP, we have defined protein coding transcripts as major non-rRNA 
targets of DDX3 binding (Fig. 11B). Those findings are in line with previous work, which 
used iCLIP to determine DDX3 binding sites to human transcriptome (Oh et al., 2016) and 
with previously reported functions of DDX3 which are related to regulation of mRNA 
translation (Lai et al., 2010; Lee et al., 2008). Binding to non-coding transcripts was also 
observed, but its frequency was modest when compared to the binding to mRNAs. We did not 
investigate potentially regulatory functions of DDX3 association with lncRNAs. In light of 
our results discussed below we can however put forward a hypothesis explaining it. It is 
possible that DDX3 association with lncRNAs reflects binding related to scanning through the 
transcriptome for start codons by the ribosome, with which the protein associates. In such a 
scenario, binding to lncRNAs would not reflect regulatory roles related to non-coding 
transcripts and would be just a side effect of ribosome activity. It is also possible that DDX3 
actually participates in translation of transcripts generally considered as non-coding. It has 
been reported that many transcripts considered as lncRNAs associate with ribosomes and give 
rise to peptides, which however may be largely non-functional (Ji et al., 2015; Bazin et al., 
2017). However, ribosomes function in cytoplasm and most human lncRNAs are localized to 
the nucleus. This fact suggests that lncRNA-DDX3 interactions are most likely independent 
of ribosomes. Interestingly we have observed that DDX3 binding to lncRNAs along transcript 
bodies exhibits a similar pattern as binding to mRNA, with highest peaks occurring in the 5’ 
end of transcripts (Fig. 17). Regulatory relevance of this binding remains unknown. The most 
obvious possibility is that DDX3 utilizes its helicase activity to resolve RNA secondary 
structures in 5’ ends of lncRNAs to regulate their interactions with other proteins. 
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5.3.2. DDX3-mRNA binding pattern suggests a role in regulation of translation initiation 
 We have determined that DDX3 binds most of the expressed mRNAs and that this 
binding preferentially takes place in transcripts 5’ UTRs around start codons. The observed 
binding pattern along the transcript body is very similar to that of eIF3B (Fig. 15A). EIF3B is 
part of translation initiation complex that has been reported to directly interact with DDX3 
(Lee et al., 2008). Those results suggest that DDX3 regulatory function on protein coding 
transcripts is centered on their 5’ UTRs and supports findings from other studies, which 
reported DDX3 function in regulation of translation initiation through interactions with 
proteins belonging to the translation initiation complex (Lee et al., 2008; Soto-Rifo et al., 
2012). Association of DDX3 with the translation initiation machinery is further supported by 
the observation that the protein binds directly to the 40S ribosome (Fig. 15D). The binding 
site was detected on helix 16 of the 18S rRNA, which is similar to binding sites identified in 
previous studies (Valentin-Vega et al., 2016; Oh et al., 2016). The position of the binding is 
compatible with interactions between DDX3 and translation initiation factors (Lee et al., 
2008). It is also in line with observations from experiments performed in yeast, where the 
DDX3 ortholog Ded1 cooperates with Translation Initiation Factor 3 (TIF3), an ortholog of 
human eIF4B, in translation initiation (Sen et al., 2016). 
5.3.3. DDX3 depletion affects mRNA abundance most likely through an indirect 
mechanism 
 Our investigation of the effects of DDX3 depletion using siRNA pools revealed 
subsets of transcripts that are affected on the level of their abundance as well as translation 
efficiency. Changes in mRNA levels were more commonly observed than changes in 
translation efficiency (Table 1). One explanation of this is that it may be caused indirectly, 
through changes of expression of proteins known to influence mRNA abundance. Among the 
genes displaying decreased translation efficiency upon DDX3 depletion we have found some 
involved in the process of transcription, such as E2F1, E2F4, TCF3, HES6, and ELK1. 
Changes of their level could indeed influence abundance of mRNAs in cells. Another possible 
explanation is that DDX3 is involved directly in regulation of mRNA stability. This potential 
mode of action of the protein is, however, unexplored and remains a matter of speculation, as 
it has not been addressed in this work or up to our knowledge in any other studies. 
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5.3.4. DDX3 regulates translation of mRNAs with structured 5’ UTRs 
 The number of transcripts, whose translation efficiency is affected by DDX3 
depletion, was small when compared to the number of transcripts identified as bound by the 
protein (Table 2). The widespread DDX3 binding to mRNAs may reflect this protein’s 
general association with ribosomes initiating translation. The protein may associate with 
ribosomes regardless of whether it is necessary for translation of a given transcript. This 
potential scenario would explain why the DDX3 depletion only significantly affects 
translation of specific mRNA targets. This assumption is in line with previous studies, which 
reported that DDX3 can associate with translation initiation factors directly, in absence of 
RNA (Lee et al., 2008). We have observed that most of the transcripts affected by DDX3 
depletion on the level of translation were identified as bound by the protein in the PAR-CLIP 
experiment (Table 2). Our observation that DDX3 depletion results in specific shift of 
ribosomes on those transcripts from coding sequences to 5’ UTRs (Fig. 14A) is in line with 
DDX3 role in translation initiation as accumulation of ribosomes in 5’ UTRs most likely 
reflects impairment of this process. 
 DDX3 has been reported in previous studies to facilitate translation initiation of 
specific mRNAs with structured 5’ UTRs (Soto-Rifo et al., 2012). Through our transcriptome-
wide approaches, we have determined that this regulation is more widespread than previously 
shown. We have established a direct link between lowered translation efficiency of mRNAs 
upon DDX3 depletion and levels of GC in their 5’ UTRs, which reflects a high potential to 
form secondary structures (Fig. 14C and Fig. 14D). Our observations led us to believe that 
DDX3 most likely controls translation initiation on mRNAs harboring complex 5’ UTRs. To 
further validate this notion, we have again looked into DDX3 binding sites established with 
PAR-CLIP and determined that high confidence protein binding takes place in GC rich 
regions (Fig. 16A) and that it is specifically increased in 5’ UTRs of mRNAs displaying lower 
translation efficiency upon DDX3 depletion (Fig. 16B). We believe that those findings 
strongly indicate that the major function of DDX3 in human cells is to facilitate translation 
initiation on transcripts harboring secondary RNA structures in their 5’ UTRs, most likely 
through its helicase activity. This mode of action could play a part in regulation of DDR, in 
which DDX3 displays increased binding to polyadenylated RNAs (Milek et al., 2017). It is 
possible that increased binding of the protein to RNAs in DDR reflects its direct regulatory 
role in translation initiation of upregulated DDR genes. In line with this assumption we have 
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observed in our experiments that a number of genes involved in regulation of DDR was bound 
by DDX3 and displayed lowered TE upon DDX3 depletion. 
5.3.5. DDX3 may have opposing roles in regulating translation initiation  
 In our analysis of translation efficiency upon DDX3 knockdown, we have observed a 
small subset of transcripts bound by DDX3, which displayed an increase in their translation 
efficiency upon the protein knock-down (Table 2). This effect is not in line with the major 
role of DDX3 our work has defined as promoting the translation initiation of transcripts with 
structured 5’ UTRs. It is possible that identification of small number of transcripts displaying 
increase in translation efficiency is simply an artifact of our analysis and does not reflect 
direct role of DDX3 in negative regulation of translation. In line with this assumption is the 
fact that we have detected mRNAs coding for histone proteins in this group of transcripts 
(Fig. 13A). Histone mRNAs do not bear a typical 3’ end and do not have polyA tails 
(Marzluff et al., 2017). We have determined mRNA abundance used for calculation of 
translation efficiency using polyadenylated fraction of transcripts. Thus, observed changes in 
translation efficiency of histone mRNAs may be a result of an experimental bias and require a 
more tailored approach for verification. The observed increase in translation efficiency may, 
however, also be a result of direct regulation mediated by the protein. In one previous study, 
DDX3 has been shown to negatively regulate cap-dependent translation of a specific mRNA 
both in vivo and in vitro in a luciferase reporter assay (Shih et al., 2008). In a later study that 
mechanism was also linked to DDX3 mediated formation of stress granules in which DDX3 is 
involved through its interactions with translation initiation factor independently of its ATPase 
and helicase activities (Shih et al., 2012). It seems possible that DDX3 has dual roles in 
binding to transcripts 5’ UTRs, facilitating translation initiation on targets bearing secondary 
RNA structures and under specific circumstances inhibiting translation initiation on others. 
Presence of DDX3 on 5’ UTRs of most expressed transcripts, which are not effected by 
DDX3 knock-down could reflect function of the protein in providing readiness of translation 
initiation machinery to quickly inhibit translation in face of potentially dangerous stresses. A 
secondary function of DDX3 as a conditional translation inhibitor could also explain our 
aforementioned observation that some mRNAs bound by this protein displayed lowered 
translation efficiency upon its depletion. This hypothesis provides an interesting potential 
follow-up to results presented in this work. Identification of changes of DDX3 binding to 
mRNAs upon stress induced formation of SGs and of associated changes in translation 
efficiency could provide important new insight into DDX3 functions. 
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5.3.6. Limitations of the approach used to study DDX3 functions 
 Functional study of DDX3 is made more difficult by the fact that it is an essential 
protein in eukaryotic cells. Traditional protein knock-outs cannot be studied due to loss of 
cells viability. Knock-down approaches, like the one used in this study, are associated with a 
certain level of the protein of interest still being expressed in cells (Fig. 12B). Those residual 
protein levels can obscure the full picture of regulatory roles played by the protein in knock-
down experiments. Moreover, the time required to achieve efficient knock-down of a protein 
with siRNAs provides cells with a possibility to adapt to gradual depletion of that protein. It 
cannot be ruled out that such an adaptation took place in case of our siRNA knock-down of 
DDX3. In this scenario full picture of regulatory roles played by DDX3 could be obscured by 
activity of proteins having some degree of functional redundancy to DDX3. To overcome 
those issues, we have attempted to develop stable cell lines allowing for a transient and quick 
(within hours) DDX3 knock-out using the auxin induced degron system. Those efforts, 
however, were not successful and further attempts to create an experimental set up to study 
effects of complete DDX3 depletion are warranted.  
 Taken together we were able to gain important new insights into regulatory roles of 
DDX3. Our results establish that the major role of the protein is regulating translation 
initiation through binding to ribosomes and 5’ UTRs of target mRNAs harboring RNA 
secondary structures. This mode of action is similar to that of DDX3 yeast ortholog Ded1, 
with a marked difference that Ded1 regulates translation initiation of a much broader fraction 





6. Supplementary tables and figures 
 
Supplementary Table 1. List of lncRNAs differentially expressed in different time points after 
induction of IR, which were identified using MCF-7 specific lncRNA annotation (Sun et al., 
2015) and were not annotated in Gencode.v19 genome annotation. Averaged FPKM values 
from two biological replicates are shown. 





8h IR  
FPKM 
16h IR  
FPKM 
24h IR  
FPKM 
LncRNA231:1 chr3:46686311-46702478 0.7 5.9 2.9 2.2 1.9 
LncRNA1868:1 chr9:138999328-139000876 1.7 2.3 4.2 6.0 5.6 
LncRNA1819:1 chr7:155000588-155010565 0.4 3.2 3.4 2.7 2.0 
LncRNA1548:1 chr11:77930120-77936399 1.8 3.3 4.0 8.3 5.3 
LncRNA641:1 chr18:23747816-23751320 3.5 2.6 2.3 1.2 0.9 
 
 
      
Supplementary Figure 1. Expression of tagged Csy4 protein in HEK293 cells. A – Western 
blot image with HA antibodies showing levels of Csy4 protein after transfection with plasmid 
encoding FLAG/HA tagged Csy4 protein (predicted molecular weight of FLAG/HA tagged 
Csy4 protein is 26.67 kDa), with different amounts of Csy4 target stem loops (SL). B – 
Western blot image with HA antibodies showing levels of Csy4 protein after transfection with 
plasmid encoding STREP/HA tagged Csy4 protein (predicted molecular weight of 
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Supplementary Figure 2. Percentages of all sequenced reads mapping to genes. exons and 
rRNA in sequencing experiments performed for polyA enriched fraction of transcripts and 
fraction of transcripts after sequential depletion of polyadenylated and ribosomal RNAs. 
Shown are average results of two biological replicates per condition. 
 
 
Supplementary Figure 3. Differences in relative number of mapped reads obtained in each 
biological replicate of sequencing experiment of transcripts depleted of polyadenylated and 
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